NDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,PHARM_CLASSES,DEASCHEDULE,NDC_EXCLUDE_FLAG,LISTING_RECORD_CERTIFIED_THROUGH,PRIMARY_ICD10,ALL_ICD10_MAPPINGS,MAPPING_CONFIDENCE
0143-9743,HUMAN PRESCRIPTION DRUG,Oxytocin,,Oxytocin,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20130213,,ANDA,ANDA200219,West-Ward Pharmaceuticals Corp,OXYTOCIN,10,[USP'U]/mL,"Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9744,HUMAN PRESCRIPTION DRUG,Granisetron Hydrochloride,,Granisetron Hydrochloride,INJECTION,INTRAVENOUS,20091223,,ANDA,ANDA078629,Hikma Pharmaceuticals USA Inc.,GRANISETRON HYDROCHLORIDE,1,mg/mL,"Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9745,HUMAN PRESCRIPTION DRUG,Granisetron Hydrochloride,,Granisetron Hydrochloride,INJECTION,INTRAVENOUS,20091223,,ANDA,ANDA078629,Hikma Pharmaceuticals USA Inc.,GRANISETRON HYDROCHLORIDE,1,mg/mL,"Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9746,HUMAN PRESCRIPTION DRUG,Terbutaline Sulfate,,Terbutaline Sulfate,INJECTION,SUBCUTANEOUS,20090520,,ANDA,ANDA078630,Hikma Pharmaceuticals USA Inc.,TERBUTALINE SULFATE,1,mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9750,HUMAN PRESCRIPTION DRUG,TESTOSTERONE ENANTHATE,,TESTOSTERONE ENANTHATE,"INJECTION, SOLUTION",INTRAMUSCULAR,20120918,,ANDA,ANDA091120,Hikma Pharmaceuticals USA Inc.,TESTOSTERONE ENANTHATE,200,mg/mL,"Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]",CIII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9753,HUMAN PRESCRIPTION DRUG,Methylprednisolone Sodium Succinate,,Methylprednisolone Sodium Succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20220926,,ANDA,ANDA203125,Hikma Pharmaceuticals USA Inc.,METHYLPREDNISOLONE SODIUM SUCCINATE,40,mg/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9754,HUMAN PRESCRIPTION DRUG,Methylprednisolone Sodium Succinate,,Methylprednisolone Sodium Succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20220926,,ANDA,ANDA203125,Hikma Pharmaceuticals USA Inc.,METHYLPREDNISOLONE SODIUM SUCCINATE,125,mg/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9782,HUMAN PRESCRIPTION DRUG,Fosphenytoin Sodium,,Fosphenytoin Sodium,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20091202,,ANDA,ANDA078765,West-Ward Pharmaceuticals Corp,FOSPHENYTOIN SODIUM,50,mg/mL,"Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9783,HUMAN PRESCRIPTION DRUG,Flumazenil,,flumazenil,"INJECTION, SOLUTION",INTRAVENOUS,20070101,,ANDA,ANDA078527,Hikma Pharmaceuticals USA Inc.,FLUMAZENIL,0.1,mg/mL,Benzodiazepine Antagonist [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9784,HUMAN PRESCRIPTION DRUG,Flumazenil,,flumazenil,"INJECTION, SOLUTION",INTRAVENOUS,20070101,,ANDA,ANDA078527,Hikma Pharmaceuticals USA Inc.,FLUMAZENIL,0.1,mg/mL,Benzodiazepine Antagonist [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9785,HUMAN PRESCRIPTION DRUG,Valproate Sodium,,Valproate Sodium,INJECTION,INTRAVENOUS,20100217,,ANDA,ANDA078523,Hikma Pharmaceuticals USA Inc.,VALPROATE SODIUM,500,mg/5mL,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9786,HUMAN PRESCRIPTION DRUG,Enalaprilat,,enalaprilat,INJECTION,INTRAVENOUS,20081223,,ANDA,ANDA078687,Hikma Pharmaceuticals USA Inc.,ENALAPRILAT DIHYDRATE,2.5,mg/2mL,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9787,HUMAN PRESCRIPTION DRUG,Enalaprilat,,enalaprilat,INJECTION,INTRAVENOUS,20081223,,ANDA,ANDA078687,Hikma Pharmaceuticals USA Inc.,ENALAPRILAT DIHYDRATE,1.25,mg/mL,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9788,HUMAN PRESCRIPTION DRUG,Fosphenytoin Sodium,,Fosphenytoin Sodium,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20091202,,ANDA,ANDA078765,West-Ward Pharmaceuticals Corp,FOSPHENYTOIN SODIUM,50,mg/mL,"Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9802,HUMAN PRESCRIPTION DRUG,Doxycycline Hyclate,,Doxycycline Hyclate,CAPSULE,ORAL,19840507,,ANDA,ANDA062396,Hikma Pharmaceuticals USA Inc.,DOXYCYCLINE HYCLATE,50,mg/1,"Tetracycline-class Drug [EPC], Tetracyclines [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9803,HUMAN PRESCRIPTION DRUG,Doxycycline Hyclate,,Doxycycline Hyclate,CAPSULE,ORAL,19840507,,ANDA,ANDA062396,Hikma Pharmaceuticals USA Inc.,DOXYCYCLINE HYCLATE,100,mg/1,"Tetracycline-class Drug [EPC], Tetracyclines [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9830,HUMAN PRESCRIPTION DRUG,Methotrexate,,Methotrexate,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS,20050906,,ANDA,ANDA040632,Hikma Pharmaceuticals USA Inc.,METHOTREXATE,1,g/1,"Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9836,HUMAN PRESCRIPTION DRUG,Penicillin V Potassium,,Penicillin V Potassium,"TABLET, FILM COATED",ORAL,20131011,,ANDA,ANDA090549,Hikma Pharmaceuticals USA Inc.,PENICILLIN V POTASSIUM,500,mg/1,"Penicillin-class Antibacterial [EPC], Penicillins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9837,HUMAN PRESCRIPTION DRUG,Penicillin V Potassium,,Penicillin V Potassium,"TABLET, FILM COATED",ORAL,20131011,,ANDA,ANDA090549,Hikma Pharmaceuticals USA Inc.,PENICILLIN V POTASSIUM,250,mg/1,"Penicillin-class Antibacterial [EPC], Penicillins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9850,HUMAN PRESCRIPTION DRUG,Methylprednisolone Sodium Succinate,,Methylprednisolone Sodium Succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20160101,,ANDA,ANDA202691,Hikma Pharmaceuticals USA Inc.,METHYLPREDNISOLONE SODIUM SUCCINATE,500,mg/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9851,HUMAN PRESCRIPTION DRUG,Methylprednisolone Sodium Succinate,,Methylprednisolone Sodium Succinate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20160101,,ANDA,ANDA202691,Hikma Pharmaceuticals USA Inc.,METHYLPREDNISOLONE SODIUM SUCCINATE,1,g/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9852,HUMAN PRESCRIPTION DRUG,Levocarnitine,,Levocarnitine,INJECTION,INTRAVENOUS,20230601,,ANDA,ANDA075567,Hikma Pharmaceuticals USA Inc.,LEVOCARNITINE,1,g/5mL,"Carnitine Analog [EPC], Carnitine [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9853,HUMAN PRESCRIPTION DRUG,Amoxicillin and Clavulanate Potassium,,Amoxicillin and Clavulanate Potassium,SUSPENSION,ORAL,20090803,,ANDA,ANDA065373,Hikma Pharmaceuticals USA Inc.,AMOXICILLIN; CLAVULANATE POTASSIUM,600; 42.9,mg/5mL; mg/5mL,"Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9856,HUMAN PRESCRIPTION DRUG,Ceftriaxone,,Ceftriaxone,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20080110,,ANDA,ANDA065342,Hikma Pharmaceuticals USA Inc.,CEFTRIAXONE SODIUM,2,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9857,HUMAN PRESCRIPTION DRUG,Ceftriaxone,,Ceftriaxone,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20080110,,ANDA,ANDA065342,Hikma Pharmaceuticals USA Inc.,CEFTRIAXONE SODIUM,1,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9858,HUMAN PRESCRIPTION DRUG,Ceftriaxone,,Ceftriaxone,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20080110,,ANDA,ANDA065342,Hikma Pharmaceuticals USA Inc.,CEFTRIAXONE SODIUM,500,mg/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9859,HUMAN PRESCRIPTION DRUG,Ceftriaxone,,ceftriaxone,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20080110,,ANDA,ANDA065342,Hikma Pharmaceuticals USA Inc.,CEFTRIAXONE SODIUM,250,mg/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9864,HUMAN PRESCRIPTION DRUG,Butorphanol Tartrate,,Butorphanol Tartrate,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20090501,,ANDA,ANDA078400,Hikma Pharmaceuticals USA Inc.,BUTORPHANOL TARTRATE,1,mg/mL,"Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]",CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9867,HUMAN PRESCRIPTION DRUG,Butorphanol Tartrate,,Butorphanol Tartrate,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20090501,,ANDA,ANDA078400,Hikma Pharmaceuticals USA Inc.,BUTORPHANOL TARTRATE,2,mg/mL,"Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]",CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9871,HUMAN PRESCRIPTION DRUG,Cladribine,,Cladribine,INJECTION,INTRAVENOUS,20000228,,ANDA,ANDA075405,Hikma Pharmaceuticals USA Inc.,CLADRIBINE,1,mg/mL,Purine Antimetabolite [EPC],,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9872,HUMAN PRESCRIPTION DRUG,Propranolol Hydrochloride,,Propranolol Hydrochloride,INJECTION,INTRAVENOUS,20080131,,ANDA,ANDA077760,Hikma Pharmaceuticals USA Inc.,PROPRANOLOL HYDROCHLORIDE,1,mg/mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9873,HUMAN PRESCRIPTION DRUG,Metoprolol Tartrate,,Metoprolol Tartrate,"INJECTION, SOLUTION",INTRAVENOUS,20070530,,ANDA,ANDA077761,Hikma Pharmaceuticals USA Inc.,METOPROLOL TARTRATE,5,mg/5mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9875,HUMAN PRESCRIPTION DRUG,Amiodarone Hydrochloride,,Amiodarone Hydrochloride,"INJECTION, SOLUTION",INTRAVENOUS,20080225,,ANDA,ANDA077234,Hikma Pharmaceuticals USA Inc.,AMIODARONE HYDROCHLORIDE,50,mg/mL,"Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9876,HUMAN PRESCRIPTION DRUG,Cefoxitin,,Cefoxitin,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20100226,,ANDA,ANDA065239,Hikma Pharmaceuticals USA Inc.,CEFOXITIN SODIUM,10,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9877,HUMAN PRESCRIPTION DRUG,Cefoxitin,,Cefoxitin,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20100312,,ANDA,ANDA065238,Hikma Pharmaceuticals USA Inc.,CEFOXITIN SODIUM,2,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9878,HUMAN PRESCRIPTION DRUG,Cefoxitin,,Cefoxitin,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20100312,,ANDA,ANDA065238,Hikma Pharmaceuticals USA Inc.,CEFOXITIN SODIUM,1,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9886,HUMAN PRESCRIPTION DRUG,Amoxicillin,,Amoxicillin,"POWDER, FOR SUSPENSION",ORAL,20060619,,ANDA,ANDA065325,Hikma Pharmaceuticals USA Inc.,AMOXICILLIN,200,mg/5mL,"Penicillin-class Antibacterial [EPC], Penicillins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9887,HUMAN PRESCRIPTION DRUG,Amoxicillin,,Amoxicillin,"POWDER, FOR SUSPENSION",ORAL,20060619,,ANDA,ANDA065325,Hikma Pharmaceuticals USA Inc.,AMOXICILLIN,400,mg/5mL,"Penicillin-class Antibacterial [EPC], Penicillins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9888,HUMAN PRESCRIPTION DRUG,Amoxicillin,,Amoxicillin,"POWDER, FOR SUSPENSION",ORAL,20060619,,ANDA,ANDA065322,Hikma Pharmaceuticals USA Inc.,AMOXICILLIN,125,mg/5mL,"Penicillin-class Antibacterial [EPC], Penicillins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9889,HUMAN PRESCRIPTION DRUG,Amoxicillin,,Amoxicillin,"POWDER, FOR SUSPENSION",ORAL,20060619,,ANDA,ANDA065322,Hikma Pharmaceuticals USA Inc.,AMOXICILLIN,250,mg/5mL,"Penicillin-class Antibacterial [EPC], Penicillins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9890,HUMAN PRESCRIPTION DRUG,Ondansetron,,Ondansetron,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20061226,,ANDA,ANDA076781,West-Ward Pharmaceuticals Corp,ONDANSETRON HYDROCHLORIDE,2,mg/mL,"Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9891,HUMAN PRESCRIPTION DRUG,Ondansetron,,Ondansetron,INJECTION,INTRAMUSCULAR; INTRAVENOUS,20061226,,ANDA,ANDA076780,West-Ward Pharmaceuticals Corp,ONDANSETRON HYDROCHLORIDE,2,mg/mL,"Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9899,HUMAN PRESCRIPTION DRUG,Fluconazole,,Fluconazole,INJECTION,INTRAVENOUS,20050823,,ANDA,ANDA076736,Hikma Pharmaceuticals USA Inc.,FLUCONAZOLE,2,mg/mL,"Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9923,HUMAN PRESCRIPTION DRUG,Cefazolin,,Cefazolin,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20010918,,ANDA,ANDA065047,Hikma Pharmaceuticals USA Inc.,CEFAZOLIN SODIUM,225,mg/mL,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9924,HUMAN PRESCRIPTION DRUG,Cefazolin,,Cefazolin,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20010918,,ANDA,ANDA065047,Hikma Pharmaceuticals USA Inc.,CEFAZOLIN SODIUM,330,mg/mL,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9927,HUMAN PRESCRIPTION DRUG,Ciprofloxacin,,Ciprofloxacin,"TABLET, FILM COATED",ORAL,20040609,,ANDA,ANDA076558,Hikma Pharmaceuticals USA Inc.,CIPROFLOXACIN HYDROCHLORIDE,250,mg/1,"Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9928,HUMAN PRESCRIPTION DRUG,Ciprofloxacin,,Ciprofloxacin,"TABLET, FILM COATED",ORAL,20040609,,ANDA,ANDA076558,Hikma Pharmaceuticals USA Inc.,CIPROFLOXACIN HYDROCHLORIDE,500,mg/1,"Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9929,HUMAN PRESCRIPTION DRUG,Ciprofloxacin,,Ciprofloxacin,"TABLET, FILM COATED",ORAL,20040609,,ANDA,ANDA076558,Hikma Pharmaceuticals USA Inc.,CIPROFLOXACIN HYDROCHLORIDE,750,mg/1,"Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9930,HUMAN PRESCRIPTION DRUG,Cefotaxime,,Cefotaxime,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20021120,,ANDA,ANDA065072,Hikma Pharmaceuticals USA Inc.,CEFOTAXIME SODIUM,500,mg/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9931,HUMAN PRESCRIPTION DRUG,Cefotaxime,,Cefotaxime,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20021120,,ANDA,ANDA065072,Hikma Pharmaceuticals USA Inc.,CEFOTAXIME SODIUM,1,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9933,HUMAN PRESCRIPTION DRUG,Cefotaxime,,Cefotaxime,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20021120,,ANDA,ANDA065072,Hikma Pharmaceuticals USA Inc.,CEFOTAXIME SODIUM,2,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9935,HUMAN PRESCRIPTION DRUG,Cefotaxime,,Cefotaxime,INJECTION,INTRAVENOUS,20021120,,ANDA,ANDA065071,Hikma Pharmaceuticals USA Inc.,CEFOTAXIME SODIUM,10,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9939,HUMAN PRESCRIPTION DRUG,Amoxicillin,,Amoxicillin,CAPSULE,ORAL,20070301,,ANDA,ANDA065291,Hikma Pharmaceuticals USA Inc.,AMOXICILLIN,500,mg/1,"Penicillin-class Antibacterial [EPC], Penicillins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9941,HUMAN PRESCRIPTION DRUG,Polymyxin B,,Polymyxin B sulfate,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC,19980601,,ANDA,ANDA060716,Hikma Pharmaceuticals USA Inc.,POLYMYXIN B SULFATE,500000,[iU]/1,"Polymyxin-class Antibacterial [EPC], Polymyxins [CS]",,N,20251231,H10.9,"[{""icd10_code"":""H10.9"",""description"":""Unspecified conjunctivitis"",""confidence"":0.4,""context"":""eye infection""},{""icd10_code"":""H40.9"",""description"":""Unspecified glaucoma"",""confidence"":0.3,""context"":""glaucoma""},{""icd10_code"":""H16.9"",""description"":""Unspecified keratitis"",""confidence"":0.3,""context"":""corneal condition""}]",0.40
0143-9976,HUMAN PRESCRIPTION DRUG,Cefuroxime,,Cefuroxime,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20040109,,ANDA,ANDA065046,Hikma Pharmaceuticals USA Inc.,CEFUROXIME SODIUM,750,mg/8mL,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9977,HUMAN PRESCRIPTION DRUG,Cefuroxime,,Cefuroxime,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20040109,,ANDA,ANDA065048,Hikma Pharmaceuticals USA Inc.,CEFUROXIME SODIUM,1.5,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9979,HUMAN PRESCRIPTION DRUG,Cefuroxime,,Cefuroxime,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,20040109,,ANDA,ANDA065048,Hikma Pharmaceuticals USA Inc.,CEFUROXIME SODIUM,750,mg/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9981,HUMAN PRESCRIPTION DRUG,Amoxicillin and Clavulanate Potassium,,Amoxicillin and Clavulanate Potassium,"POWDER, FOR SUSPENSION",ORAL,20071201,,ANDA,ANDA065191,Hikma Pharmaceuticals USA Inc.,AMOXICILLIN; CLAVULANIC ACID,200; 28.5,mg/5mL; mg/5mL,"Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9982,HUMAN PRESCRIPTION DRUG,Amoxicillin and Clavulanate Potassium,,Amoxicillin and Clavulanate Potassium,"POWDER, FOR SUSPENSION",ORAL,20071201,,ANDA,ANDA065191,Hikma Pharmaceuticals USA Inc.,AMOXICILLIN; CLAVULANIC ACID,400; 57,mg/5mL; mg/5mL,"Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0143-9983,HUMAN PRESCRIPTION DRUG,Cefazolin,,Cefazolin,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,20041018,,ANDA,ANDA065143,Hikma Pharmaceuticals USA Inc.,CEFAZOLIN SODIUM,10,g/1,"Cephalosporin Antibacterial [EPC], Cephalosporins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0159-2200,HUMAN OTC DRUG,Selan Plus Zinc Oxide,,Selan Plus Zinc Oxide,CREAM,TOPICAL,19970829,,OTC MONOGRAPH DRUG,M016,"Trividia Manufacturing Solutions, Inc",DIMETHICONE; ZINC OXIDE,2.1; 2,g/100g; g/100g,Skin Barrier Activity [PE],,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0159-2500,HUMAN OTC DRUG,Selan Antifungal,,Selan Antifungal,CREAM,TOPICAL,20031105,,OTC MONOGRAPH DRUG,M005,"Trividia Manufacturing Solutions, Inc",MICONAZOLE NITRATE,2,g/100g,"Azole Antifungal [EPC], Azoles [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0002,HUMAN PRESCRIPTION DRUG,triamcinolone acetonide,,triamcinolone acetonide,CREAM,TOPICAL,19780309,,ANDA,ANDA085692,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,TRIAMCINOLONE ACETONIDE,5,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0003,HUMAN PRESCRIPTION DRUG,triamcinolone acetonide,,triamcinolone acetonide,CREAM,TOPICAL,19780309,,ANDA,ANDA085692,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,TRIAMCINOLONE ACETONIDE,0.25,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0004,HUMAN PRESCRIPTION DRUG,triamcinolone acetonide,,triamcinolone acetonide,CREAM,TOPICAL,19780309,,ANDA,ANDA085692,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,TRIAMCINOLONE ACETONIDE,1,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0005,HUMAN PRESCRIPTION DRUG,Triamcinolone Acetonide,,triamcinolone acetonide,OINTMENT,TOPICAL,19780214,,ANDA,ANDA085691,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,TRIAMCINOLONE ACETONIDE,0.25,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0006,HUMAN PRESCRIPTION DRUG,Triamcinolone Acetonide,,triamcinolone acetonide,OINTMENT,TOPICAL,19780214,,ANDA,ANDA085691,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,TRIAMCINOLONE ACETONIDE,1,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0015,HUMAN PRESCRIPTION DRUG,hydrocortisone,,Hydrocortisone,CREAM,TOPICAL,19760430,,ANDA,ANDA080693,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,HYDROCORTISONE,10,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0020,HUMAN PRESCRIPTION DRUG,Hydrocortisone,,Hydrocortisone,OINTMENT,TOPICAL,19750416,,ANDA,ANDA080692,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,HYDROCORTISONE,10,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0033,HUMAN PRESCRIPTION DRUG,Betamethasone Valerate,,betamethasone valerate,OINTMENT,TOPICAL,19830831,,NDA,NDA018865,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,BETAMETHASONE VALERATE,1,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0040,HUMAN PRESCRIPTION DRUG,Betamethasone Valerate,,betamethasone valerate,CREAM,TOPICAL,19830831,,NDA,NDA018861,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,BETAMETHASONE VALERATE,1,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0041,HUMAN PRESCRIPTION DRUG,Betamethasone Valerate,,betamethasone valerate,LOTION,TOPICAL,19830831,,NDA,NDA018866,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,BETAMETHASONE VALERATE,1,mg/mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0055,HUMAN PRESCRIPTION DRUG,Betamethasone Dipropionate,,Betamethasone Dipropionate,CREAM,TOPICAL,19840626,,NDA,NDA019137,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,BETAMETHASONE DIPROPIONATE,0.5,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0056,HUMAN PRESCRIPTION DRUG,Betamethasone Dipropionate,,Betamethasone Dipropionate,OINTMENT,TOPICAL,19840904,,NDA,NDA019141,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,BETAMETHASONE DIPROPIONATE,0.5,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0057,HUMAN PRESCRIPTION DRUG,Betamethasone Dipropionate,,Betamethasone Dipropionate,LOTION,TOPICAL,19850812,,ANDA,ANDA070275,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,BETAMETHASONE DIPROPIONATE,0.5,mg/mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0059,HUMAN PRESCRIPTION DRUG,Fluocinolone Acetonide,,fluocinolone acetonide,SOLUTION,TOPICAL,19821216,,ANDA,ANDA088167,Fougera Pharmaceuticals Inc.,FLUOCINOLONE ACETONIDE,0.1,mg/mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0064,HUMAN PRESCRIPTION DRUG,Fluocinolone Acetonide,,fluocinolone acetonide,OINTMENT,TOPICAL,19821216,,ANDA,ANDA088168,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,FLUOCINOLONE ACETONIDE,0.25,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0080,HUMAN PRESCRIPTION DRUG,Hydrocortisone,,Hydrocortisone,CREAM,TOPICAL,19861216,,ANDA,ANDA089414,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,HYDROCORTISONE,25,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0099,HUMAN PRESCRIPTION DRUG,ketoconazole,,ketoconazole,CREAM,TOPICAL,20040428,,ANDA,ANDA076294,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,KETOCONAZOLE,20,mg/g,"Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0126,HUMAN OTC DRUG,Swim-EAR,,Swim-EAR,SOLUTION,AURICULAR (OTIC),19700403,,OTC MONOGRAPH DRUG,M014,Fougera Pharmaceuticals Inc.,ISOPROPYL ALCOHOL,950,mg/mL,,,N,20251231,H60.9,"[{""icd10_code"":""H60.9"",""description"":""Unspecified otitis externa"",""confidence"":0.5,""context"":""ear infection""},{""icd10_code"":""H61.20"",""description"":""Impacted cerumen, unspecified ear"",""confidence"":0.3,""context"":""ear wax""},{""icd10_code"":""H92.09"",""description"":""Otalgia, unspecified ear"",""confidence"":0.2,""context"":""ear pain""}]",0.50
0168-0133,HUMAN PRESCRIPTION DRUG,Clotrimazole,,clotrimazole,CREAM,TOPICAL,20080902,,ANDA,ANDA078338,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,CLOTRIMAZOLE,10,mg/g,"Azole Antifungal [EPC], Azoles [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0134,HUMAN PRESCRIPTION DRUG,fluocinonide,,fluocinonide,SOLUTION,TOPICAL,19950227,,ANDA,ANDA072934,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,FLUOCINONIDE,0.5,mg/mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0146,HUMAN PRESCRIPTION DRUG,Hydrocortisone,,Hydrocortisone,OINTMENT,TOPICAL,19930528,,ANDA,ANDA081203,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,HYDROCORTISONE,25,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0162,HUMAN PRESCRIPTION DRUG,Clobetasol Propionate,,clobetasol propionate,OINTMENT,TOPICAL,19960223,,ANDA,ANDA074407,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,CLOBETASOL PROPIONATE,0.5,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0163,HUMAN PRESCRIPTION DRUG,Clobetasol Propionate,,clobetasol propionate,CREAM,TOPICAL,19960930,,ANDA,ANDA074392,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,CLOBETASOL PROPIONATE,0.5,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0201,HUMAN PRESCRIPTION DRUG,clindamycin phosphate,,clindamycin phosphate,SOLUTION,TOPICAL,19970605,,ANDA,ANDA064159,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,CLINDAMYCIN PHOSPHATE,10,mg/mL,"Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0202,HUMAN PRESCRIPTION DRUG,clindamycin phosphate,,clindamycin phosphate,GEL,TOPICAL,20000128,,ANDA,ANDA064160,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,CLINDAMYCIN PHOSPHATE,10,mg/g,"Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0203,HUMAN PRESCRIPTION DRUG,clindamycin phosphate,,clindamycin phosphate,LOTION,TOPICAL,20020131,,ANDA,ANDA065067,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,CLINDAMYCIN PHOSPHATE,10,mg/mL,"Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0204,HUMAN PRESCRIPTION DRUG,Lidocaine,,Lidocaine,OINTMENT,TOPICAL,19720630,,ANDA,ANDA080198,Fougera Pharmaceuticals Inc.,LIDOCAINE,50,mg/g,"Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0258,HUMAN PRESCRIPTION DRUG,Clotrimazole and Betamethasone Dipropionate,,Clotrimazole and Betamethasone Dipropionate,CREAM,TOPICAL,20010605,,ANDA,ANDA075502,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE,.5; 10,mg/g; mg/g,"Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0263,HUMAN PRESCRIPTION DRUG,Alclometasone Dipropionate,,alclometasone dipropionate,CREAM,TOPICAL,20050712,,ANDA,ANDA076973,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,ALCLOMETASONE DIPROPIONATE,0.5,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0267,HUMAN PRESCRIPTION DRUG,Betamethasone Dipropionate,,Betamethasone Dipropionate,"LOTION, AUGMENTED",TOPICAL,20070521,,ANDA,ANDA077111,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,BETAMETHASONE DIPROPIONATE,0.5,mg/mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0268,HUMAN PRESCRIPTION DRUG,Betamethasone Dipropionate,,betamethasone dipropionate,"OINTMENT, AUGMENTED",TOPICAL,19990622,,ANDA,ANDA075373,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,BETAMETHASONE DIPROPIONATE,0.5,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0269,HUMAN PRESCRIPTION DRUG,Clobetasol Propionate,,Clobetasol Propionate,SOLUTION,TOPICAL,19990208,,ANDA,ANDA075391,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,CLOBETASOL PROPIONATE,0.5,mg/mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0277,HUMAN PRESCRIPTION DRUG,Clindamycin Phosphate,,clindamycin phosphate,CREAM,VAGINAL,20041227,,ANDA,ANDA065139,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,CLINDAMYCIN PHOSPHATE,20,mg/g,"Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0168-0278,HUMAN PRESCRIPTION DRUG,Amcinonide,,Amcinonide,CREAM,TOPICAL,20030515,,ANDA,ANDA076065,Fougera Pharmaceuticals Inc.,AMCINONIDE,1,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0293,HUMAN PRESCRIPTION DRUG,Clobetasol Propionate,,clobetasol propionate,GEL,TOPICAL,20000215,,ANDA,ANDA075368,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,CLOBETASOL PROPIONATE,0.5,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0301,HUMAN PRESCRIPTION DRUG,Clobetasol Propionate (emollient),,clobetasol propionate,CREAM,TOPICAL,19990526,,ANDA,ANDA075430,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,CLOBETASOL PROPIONATE,0.5,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0323,HUMAN PRESCRIPTION DRUG,Metronidazole,,Metronidazole,CREAM,TOPICAL,20040528,,ANDA,ANDA076408,Fougera Pharmaceuticals Inc.,METRONIDAZOLE,7.5,mg/g,"Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0332,HUMAN PRESCRIPTION DRUG,FLUTICASONE PROPIONATE,,fluticasone propionate,CREAM,TOPICAL,20040514,,ANDA,ANDA076451,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,FLUTICASONE PROPIONATE,0.5,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0346,HUMAN PRESCRIPTION DRUG,Terconazole,,terconazole,CREAM,VAGINAL,20050218,,ANDA,ANDA076712,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,TERCONAZOLE,4,mg/g,"Azole Antifungal [EPC], Azoles [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0168-0347,HUMAN PRESCRIPTION DRUG,Terconazole,Vaginal Cream 0.8%,terconazole,CREAM,VAGINAL,20050201,,NDA,NDA021735,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,TERCONAZOLE,8,mg/g,"Azole Antifungal [EPC], Azoles [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0168-0357,HUMAN PRESCRIPTION DRUG,Lidocaine and Prilocaine,,lidocaine and prilocaine,CREAM,TOPICAL,20030818,,ANDA,ANDA076453,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,LIDOCAINE; PRILOCAINE,25; 25,mg/g; mg/g,"Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0358,HUMAN PRESCRIPTION DRUG,Oxiconazole Nitrate,,Oxiconazole Nitrate,CREAM,TOPICAL,20160309,,NDA AUTHORIZED GENERIC,NDA019828,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,OXICONAZOLE NITRATE,10,mg/g,"Azole Antifungal [EPC], Azoles [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0383,HUMAN PRESCRIPTION DRUG,Metronidazole,,Metronidazole,LOTION,TOPICAL,20060524,,ANDA,ANDA077197,Fougera Pharmaceuticals Inc.,METRONIDAZOLE,7.5,mg/mL,"Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0416,HUMAN PRESCRIPTION DRUG,Tacrolimus,,tacrolimus,OINTMENT,TOPICAL,20140909,,ANDA,ANDA200744,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,TACROLIMUS,1,mg/g,"Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0417,HUMAN PRESCRIPTION DRUG,Tacrolimus,,tacrolimus,OINTMENT,TOPICAL,20140909,,ANDA,ANDA200744,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,TACROLIMUS,0.3,mg/g,"Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0168-0424,HUMAN PRESCRIPTION DRUG,Adapalene,,adapalene,CREAM,TOPICAL,20100630,,ANDA,ANDA090824,E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.,ADAPALENE,1,mg/g,"Retinoid [EPC], Retinoids [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0169-1401,HUMAN PRESCRIPTION DRUG,Macrilen,,Macimorelin acetate,"GRANULE, FOR SOLUTION",ORAL,20220131,20270228,NDA,NDA205598,Novo Nordisk,MACIMORELIN,60,mg/mg,"Growth Hormone Secretagogue Receptor Agonist [EPC], Growth Hormone Secretagogue Receptor Agonists [MoA]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-1833,HUMAN OTC DRUG,Novolin,R,Human Insulin,"INJECTION, SOLUTION",SUBCUTANEOUS,19910625,,BLA,BLA019938,Novo Nordisk,INSULIN HUMAN,100,[iU]/mL,"Insulin [CS], Insulin [EPC]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-1834,HUMAN OTC DRUG,Novolin,N,Human Insulin,"INJECTION, SUSPENSION",SUBCUTANEOUS,19910701,,BLA,BLA019959,Novo Nordisk,INSULIN HUMAN,100,[iU]/mL,"Insulin [CS], Insulin [EPC]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-1837,HUMAN OTC DRUG,Novolin,70/30,Human Insulin,"INJECTION, SUSPENSION",SUBCUTANEOUS,19910625,,BLA,BLA019991,Novo Nordisk,INSULIN HUMAN,100,[iU]/mL,"Insulin [CS], Insulin [EPC]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-1912,HUMAN PRESCRIPTION DRUG,Zegalogue,,dasiglucagon,"INJECTION, SOLUTION",SUBCUTANEOUS,20230626,,NDA,NDA214231,Novo Nordisk,DASIGLUCAGON,0.6,mg/.6mL,"Antihypoglycemic Agent [EPC], Glucagon Receptor Agonists [MoA], Increased Glycogenolysis [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-1913,HUMAN PRESCRIPTION DRUG,Zegalogue,,dasiglucagon,"INJECTION, SOLUTION",SUBCUTANEOUS,20230626,,NDA,NDA214231,Novo Nordisk,DASIGLUCAGON,0.6,mg/.6mL,"Antihypoglycemic Agent [EPC], Glucagon Receptor Agonists [MoA], Increased Glycogenolysis [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-2001,HUMAN PRESCRIPTION DRUG,Insulin Diluting Medium for NovoLog,,water injection,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,20010827,,BLA,BLA020986,Novo Nordisk,WATER,1,mL/mL,,,N,20261231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-2030,HUMAN PRESCRIPTION DRUG,SOGROYA,,somapacitan-beco,"INJECTION, SOLUTION",SUBCUTANEOUS,20230501,,BLA,BLA761156,Novo Nordisk,SOMAPACITAN,6.7,mg/mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-2035,HUMAN PRESCRIPTION DRUG,SOGROYA,,somapacitan-beco,"INJECTION, SOLUTION",SUBCUTANEOUS,20230501,,BLA,BLA761156,Novo Nordisk,SOMAPACITAN,3.3,mg/mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-2037,HUMAN PRESCRIPTION DRUG,SOGROYA,,somapacitan-beco,"INJECTION, SOLUTION",SUBCUTANEOUS,20230501,,BLA,BLA761156,Novo Nordisk,SOMAPACITAN,10,mg/mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-2080,HUMAN PRESCRIPTION DRUG,Alhemo,,concizumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20250219,,BLA,BLA761315,Novo Nordisk,CONCIZUMAB,100,mg/mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-2081,HUMAN PRESCRIPTION DRUG,Alhemo,,concizumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20250219,,BLA,BLA761315,Novo Nordisk,CONCIZUMAB,100,mg/mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-2084,HUMAN PRESCRIPTION DRUG,Alhemo,,concizumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20250219,,BLA,BLA761315,Novo Nordisk,CONCIZUMAB,40,mg/mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-2100,HUMAN PRESCRIPTION DRUG,NOVOLOG,,insulin aspart,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,20010827,,BLA,BLA020986,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20261231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-2101,HUMAN PRESCRIPTION DRUG,NOVOLOG,,insulin aspart,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,20030122,,BLA,BLA020986,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20261231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-2200,HUMAN PRESCRIPTION DRUG,NovoLog Mix 70/30,,insulin aspart,"INJECTION, SUSPENSION",SUBCUTANEOUS,20011101,,BLA,BLA021172,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-2201,HUMAN PRESCRIPTION DRUG,NovoLog Mix 70/30,,insulin aspart,"INJECTION, SUSPENSION",SUBCUTANEOUS,20020911,,BLA,BLA021172,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-2550,HUMAN PRESCRIPTION DRUG,Tresiba,,insulin degludec,"INJECTION, SOLUTION",SUBCUTANEOUS,20150925,,BLA,BLA203314,Novo Nordisk,INSULIN DEGLUDEC,200,U/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-2660,HUMAN PRESCRIPTION DRUG,Tresiba,,insulin degludec,"INJECTION, SOLUTION",SUBCUTANEOUS,20150925,,BLA,BLA203314,Novo Nordisk,INSULIN DEGLUDEC,100,U/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-2662,HUMAN PRESCRIPTION DRUG,Tresiba,,insulin degludec,"INJECTION, SOLUTION",SUBCUTANEOUS,20181121,,BLA,BLA203314,Novo Nordisk,INSULIN DEGLUDEC,100,U/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-2800,HUMAN PRESCRIPTION DRUG,Saxenda,,liraglutide,"INJECTION, SOLUTION",SUBCUTANEOUS,20141231,,NDA,NDA206321,Novo Nordisk,LIRAGLUTIDE,6,mg/mL,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-2911,HUMAN PRESCRIPTION DRUG,Xultophy 100/3.6,,insulin degludec and liraglutide,"INJECTION, SOLUTION",SUBCUTANEOUS,20161121,,BLA,BLA208583,Novo Nordisk,INSULIN DEGLUDEC; LIRAGLUTIDE,100; 3.6,[iU]/mL; mg/mL,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Insulin Analog [EPC], Insulin [CS]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-3003,HUMAN OTC DRUG,Novolin,R,Human Insulin,"INJECTION, SOLUTION",SUBCUTANEOUS,20190906,,BLA,BLA019938,Novo Nordisk,INSULIN HUMAN,100,[iU]/mL,"Insulin [CS], Insulin [EPC]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-3004,HUMAN OTC DRUG,Novolin,N,Human Insulin,"INJECTION, SUSPENSION",SUBCUTANEOUS,20190906,,BLA,BLA019959,Novo Nordisk,INSULIN HUMAN,100,[iU]/mL,"Insulin [CS], Insulin [EPC]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-3007,HUMAN OTC DRUG,Novolin,70/30,Human Insulin,"INJECTION, SUSPENSION",SUBCUTANEOUS,20180601,,BLA,BLA019991,Novo Nordisk,INSULIN HUMAN,100,[iU]/mL,"Insulin [CS], Insulin [EPC]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-3201,HUMAN PRESCRIPTION DRUG,Fiasp,,insulin aspart injection,"INJECTION, SOLUTION",SUBCUTANEOUS,20171020,,BLA,BLA208751,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-3204,HUMAN PRESCRIPTION DRUG,Fiasp,,insulin aspart injection,"INJECTION, SOLUTION",SUBCUTANEOUS,20171020,,BLA,BLA208751,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-3205,HUMAN PRESCRIPTION DRUG,Fiasp,,insulin aspart injection,"INJECTION, SOLUTION",SUBCUTANEOUS,20171020,,BLA,BLA208751,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-3206,HUMAN PRESCRIPTION DRUG,Fiasp,,insulin aspart,"INJECTION, SOLUTION",SUBCUTANEOUS,20171020,,BLA,BLA208751,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-3303,HUMAN PRESCRIPTION DRUG,NOVOLOG,,insulin aspart,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,20010827,,BLA,BLA020986,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20261231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-3685,HUMAN PRESCRIPTION DRUG,NovoLog Mix 70/30,,insulin aspart,"INJECTION, SUSPENSION",SUBCUTANEOUS,20011101,,BLA,BLA021172,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-3687,HUMAN PRESCRIPTION DRUG,Levemir,,insulin detemir,"INJECTION, SOLUTION",SUBCUTANEOUS,20060327,20260831,BLA,BLA021536,Novo Nordisk,INSULIN DETEMIR,100,[iU]/mL,"Insulin Analog [EPC], Insulin [Chemical/Ingredient]",,N,,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-3696,HUMAN PRESCRIPTION DRUG,NovoLog Mix 70/30,,insulin aspart,"INJECTION, SUSPENSION",SUBCUTANEOUS,20020911,,BLA,BLA021172,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20251231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-4060,HUMAN PRESCRIPTION DRUG,Victoza,,liraglutide,INJECTION,SUBCUTANEOUS,20100125,,NDA,NDA022341,Novo Nordisk,LIRAGLUTIDE,6,mg/mL,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4130,HUMAN PRESCRIPTION DRUG,Ozempic,,semaglutide,"INJECTION, SOLUTION",SUBCUTANEOUS,20200930,,NDA,NDA209637,Novo Nordisk,SEMAGLUTIDE,1.34,mg/mL,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4132,HUMAN PRESCRIPTION DRUG,Ozempic,,semaglutide,"INJECTION, SOLUTION",SUBCUTANEOUS,20171206,20250930,NDA,NDA209637,Novo Nordisk,SEMAGLUTIDE,1.34,mg/mL,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4181,HUMAN PRESCRIPTION DRUG,Ozempic,,semaglutide,"INJECTION, SOLUTION",SUBCUTANEOUS,20221007,,NDA,NDA209637,Novo Nordisk,SEMAGLUTIDE,0.68,mg/mL,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4303,HUMAN PRESCRIPTION DRUG,RYBELSUS,,Oral Semaglutide,TABLET,ORAL,20190920,,NDA,NDA213051,Novo Nordisk,SEMAGLUTIDE,3,mg/1,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4307,HUMAN PRESCRIPTION DRUG,RYBELSUS,,Oral Semaglutide,TABLET,ORAL,20190920,,NDA,NDA213051,Novo Nordisk,SEMAGLUTIDE,7,mg/1,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4314,HUMAN PRESCRIPTION DRUG,RYBELSUS,,Oral Semaglutide,TABLET,ORAL,20190920,,NDA,NDA213051,Novo Nordisk,SEMAGLUTIDE,14,mg/1,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4501,HUMAN PRESCRIPTION DRUG,WEGOVY,,semaglutide,"INJECTION, SOLUTION",SUBCUTANEOUS,20210605,,NDA,NDA215256,Novo Nordisk,SEMAGLUTIDE,1,mg/.5mL,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4505,HUMAN PRESCRIPTION DRUG,WEGOVY,,semaglutide,"INJECTION, SOLUTION",SUBCUTANEOUS,20210605,,NDA,NDA215256,Novo Nordisk,SEMAGLUTIDE,0.5,mg/.5mL,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4517,HUMAN PRESCRIPTION DRUG,WEGOVY,,semaglutide,"INJECTION, SOLUTION",SUBCUTANEOUS,20210605,,NDA,NDA215256,Novo Nordisk,SEMAGLUTIDE,1.7,mg/.75mL,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4524,HUMAN PRESCRIPTION DRUG,WEGOVY,,semaglutide,"INJECTION, SOLUTION",SUBCUTANEOUS,20210605,,NDA,NDA215256,Novo Nordisk,SEMAGLUTIDE,2.4,mg/.75mL,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4525,HUMAN PRESCRIPTION DRUG,WEGOVY,,semaglutide,"INJECTION, SOLUTION",SUBCUTANEOUS,20210605,,NDA,NDA215256,Novo Nordisk,SEMAGLUTIDE,0.25,mg/.5mL,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4772,HUMAN PRESCRIPTION DRUG,Ozempic,,semaglutide,"INJECTION, SOLUTION",SUBCUTANEOUS,20220425,,NDA,NDA209637,Novo Nordisk,SEMAGLUTIDE,2.68,mg/mL,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4804,HUMAN PRESCRIPTION DRUG,RYBELSUS,,Oral Semaglutide,TABLET,ORAL,20190920,,NDA,NDA213051,Novo Nordisk,SEMAGLUTIDE,4,mg/1,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4809,HUMAN PRESCRIPTION DRUG,RYBELSUS,,Oral Semaglutide,TABLET,ORAL,20190920,,NDA,NDA213051,Novo Nordisk,SEMAGLUTIDE,9,mg/1,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-4815,HUMAN PRESCRIPTION DRUG,RYBELSUS,,Oral Semaglutide,TABLET,ORAL,20190920,,NDA,NDA213051,Novo Nordisk,SEMAGLUTIDE,1.5,mg/1,"GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-5176,HUMAN PRESCRIPTION DRUG,Vagifem,,estradiol,INSERT,VAGINAL,20100111,,NDA,NDA020908,Novo Nordisk,ESTRADIOL,10,ug/1,"Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-5306,HUMAN PRESCRIPTION DRUG,RIVFLOZA,,nedosiran,"INJECTION, SOLUTION",SUBCUTANEOUS,20240219,,NDA,NDA215842,Novo Nordisk,NEDOSIRAN SODIUM,160,mg/mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-5307,HUMAN PRESCRIPTION DRUG,RIVFLOZA,,nedosiran,"INJECTION, SOLUTION",SUBCUTANEOUS,20240219,,NDA,NDA215842,Novo Nordisk,NEDOSIRAN SODIUM,128,mg/.8mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-5308,HUMAN PRESCRIPTION DRUG,RIVFLOZA,,nedosiran,"INJECTION, SOLUTION",SUBCUTANEOUS,20240219,,NDA,NDA215842,Novo Nordisk,NEDOSIRAN SODIUM,80,mg/.5mL,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-6338,HUMAN PRESCRIPTION DRUG,NOVOLOG,,insulin aspart,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,20131031,,BLA,BLA020986,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20261231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-6339,HUMAN PRESCRIPTION DRUG,NOVOLOG,,insulin aspart,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,20030122,,BLA,BLA020986,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20261231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-6432,HUMAN PRESCRIPTION DRUG,Levemir,,insulin detemir,"INJECTION, SOLUTION",SUBCUTANEOUS,20131031,20260630,BLA,BLA021536,Novo Nordisk,INSULIN DETEMIR,100,[iU]/mL,"Insulin Analog [EPC], Insulin [Chemical/Ingredient]",,N,,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-7010,PLASMA DERIVATIVE,NovoSeven,RT,Coagulation Factor VIIa (Recombinant),KIT,,20080430,,BLA,BLA103665,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7013,PLASMA DERIVATIVE,TRETTEN,,Coagulation Factor XIII A-Subunit (Recombinant),KIT,,20131223,,BLA,BLA125398,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7020,PLASMA DERIVATIVE,NovoSeven,RT,Coagulation Factor VIIa (Recombinant),KIT,,20080430,,BLA,BLA103665,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7040,PLASMA DERIVATIVE,NovoSeven,RT,Coagulation Factor VIIa (Recombinant),KIT,,20100806,,BLA,BLA103665,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7050,PLASMA DERIVATIVE,NovoSeven,RT,Coagulation Factor VIIa (Recombinant),KIT,,20080430,,BLA,BLA103665,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7201,PLASMA DERIVATIVE,NovoSeven,RT,Coagulation Factor VIIa (Recombinant),KIT,,20121029,,BLA,BLA103665,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7202,PLASMA DERIVATIVE,NovoSeven,RT,Coagulation Factor VIIa (Recombinant),KIT,,20121029,,BLA,BLA103665,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7205,PLASMA DERIVATIVE,NovoSeven,RT,Coagulation Factor VIIa (Recombinant),KIT,,20121029,,BLA,BLA103665,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7208,PLASMA DERIVATIVE,NovoSeven,RT,Coagulation Factor VIIa (Recombinant),KIT,,20121029,,BLA,BLA103665,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7501,HUMAN PRESCRIPTION DRUG,NOVOLOG,,insulin aspart,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,20010827,,BLA,BLA020986,Novo Nordisk,INSULIN ASPART,100,[iU]/mL,"Insulin Analog [EPC], Insulin [CS]",,N,20261231,E11.9,"[{""icd10_code"":""E10.9"",""description"":""Type 1 diabetes mellitus without complications"",""confidence"":0.3,""context"":""insulin-dependent""},{""icd10_code"":""E11.9"",""description"":""Type 2 diabetes mellitus without complications"",""confidence"":0.6,""context"":""most common""},{""icd10_code"":""E13.9"",""description"":""Other specified diabetes mellitus without complications"",""confidence"":0.1,""context"":""secondary diabetes""}]",0.60
0169-7703,HUMAN PRESCRIPTION DRUG,Norditropin,,somatropin,"INJECTION, SOLUTION",SUBCUTANEOUS,20090330,,BLA,BLA021148,Novo Nordisk,SOMATROPIN,30,mg/3mL,"Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7704,HUMAN PRESCRIPTION DRUG,Norditropin,,somatropin,"INJECTION, SOLUTION",SUBCUTANEOUS,20050103,,BLA,BLA021148,Novo Nordisk,SOMATROPIN,5,mg/1.5mL,"Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7705,HUMAN PRESCRIPTION DRUG,Norditropin,,somatropin,"INJECTION, SOLUTION",SUBCUTANEOUS,20060102,,BLA,BLA021148,Novo Nordisk,SOMATROPIN,10,mg/1.5mL,"Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7708,HUMAN PRESCRIPTION DRUG,Norditropin,,somatropin,"INJECTION, SOLUTION",SUBCUTANEOUS,20050103,,BLA,BLA021148,Novo Nordisk,SOMATROPIN,15,mg/1.5mL,"Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7810,PLASMA DERIVATIVE,NOVOEIGHT,,antihemophilic factor recombinant,KIT,,20150401,,BLA,BLA125466,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7815,PLASMA DERIVATIVE,NOVOEIGHT,,antihemophilic factor recombinant,KIT,,20150401,,BLA,BLA125466,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7820,PLASMA DERIVATIVE,NOVOEIGHT,,antihemophilic factor recombinant,KIT,,20150401,,BLA,BLA125466,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7825,PLASMA DERIVATIVE,NOVOEIGHT,,antihemophilic factor recombinant,KIT,,20150401,,BLA,BLA125466,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7830,PLASMA DERIVATIVE,NOVOEIGHT,,antihemophilic factor recombinant,KIT,,20150401,,BLA,BLA125466,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7850,PLASMA DERIVATIVE,NOVOEIGHT,,antihemophilic factor recombinant,KIT,,20150401,,BLA,BLA125466,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7901,HUMAN PRESCRIPTION DRUG,REBINYN,,"coagulation factor IX recombinant, GlycoPEGylated",KIT,,20171201,,BLA,BLA125611,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7902,HUMAN PRESCRIPTION DRUG,REBINYN,,"coagulation factor IX recombinant, GlycoPEGylated",KIT,,20171201,,BLA,BLA125611,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7903,HUMAN PRESCRIPTION DRUG,REBINYN,,"coagulation factor IX recombinant, GlycoPEGylated",KIT,,20220811,,BLA,BLA125611,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-7905,HUMAN PRESCRIPTION DRUG,REBINYN,,"coagulation factor IX recombinant, GlycoPEGylated",KIT,,20171201,,BLA,BLA125611,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-8055,PLASMA DERIVATIVE,ESPEROCT,,"antihemophilic factor (recombinant), glycopegylated-exei",KIT,,20190219,,BLA,BLA125671,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-8100,PLASMA DERIVATIVE,ESPEROCT,,"antihemophilic factor (recombinant), glycopegylated-exei",KIT,,20190219,,BLA,BLA125671,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-8150,PLASMA DERIVATIVE,ESPEROCT,,"antihemophilic factor (recombinant), glycopegylated-exei",KIT,,20190219,,BLA,BLA125671,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-8200,PLASMA DERIVATIVE,ESPEROCT,,"antihemophilic factor (recombinant), glycopegylated-exei",KIT,,20190219,,BLA,BLA125671,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-8300,PLASMA DERIVATIVE,ESPEROCT,,"antihemophilic factor (recombinant), glycopegylated-exei",KIT,,20190219,,BLA,BLA125671,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-8400,PLASMA DERIVATIVE,ESPEROCT,,"antihemophilic factor (recombinant), glycopegylated-exei",KIT,,20190219,,BLA,BLA125671,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0169-8500,PLASMA DERIVATIVE,ESPEROCT,,"antihemophilic factor (recombinant), glycopegylated-exei",KIT,,20190219,,BLA,BLA125671,Novo Nordisk,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-2083,HUMAN PRESCRIPTION DRUG,Hydrochlorothiazide,,Hydrochlorothiazide,TABLET,ORAL,19730112,,ANDA,ANDA083177,"Teva Pharmaceuticals USA, Inc.",HYDROCHLOROTHIAZIDE,25,mg/1,"Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-2089,HUMAN PRESCRIPTION DRUG,Hydrochlorothiazide,,Hydrochlorothiazide,TABLET,ORAL,19800107,,ANDA,ANDA083177,"Teva Pharmaceuticals USA, Inc.",HYDROCHLOROTHIAZIDE,50,mg/1,"Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-3444,HUMAN PRESCRIPTION DRUG,Hydrochlorothiazide,,Hydrochlorothiazide,TABLET,ORAL,20250603,,ANDA,ANDA083177,"Teva Pharmaceuticals USA, Inc.",HYDROCHLOROTHIAZIDE,12.5,mg/1,"Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-3925,HUMAN PRESCRIPTION DRUG,Diazepam,,Diazepam,TABLET,ORAL,19861210,,ANDA,ANDA071307,"Teva Pharmaceuticals USA, Inc.",DIAZEPAM,2,mg/1,"Benzodiazepine [EPC], Benzodiazepines [CS]",CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-3926,HUMAN PRESCRIPTION DRUG,Diazepam,,Diazepam,TABLET,ORAL,19861210,,ANDA,ANDA071321,"Teva Pharmaceuticals USA, Inc.",DIAZEPAM,5,mg/1,"Benzodiazepine [EPC], Benzodiazepines [CS]",CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-3927,HUMAN PRESCRIPTION DRUG,Diazepam,,Diazepam,TABLET,ORAL,19861210,,ANDA,ANDA071322,"Teva Pharmaceuticals USA, Inc.",DIAZEPAM,10,mg/1,"Benzodiazepine [EPC], Benzodiazepines [CS]",CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-4096,HUMAN PRESCRIPTION DRUG,Baclofen,,Baclofen,TABLET,ORAL,19880721,,ANDA,ANDA072234,"Teva Pharmaceuticals USA, Inc.",BACLOFEN,10,mg/1,"GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-4097,HUMAN PRESCRIPTION DRUG,Baclofen,,Baclofen,TABLET,ORAL,19880721,,ANDA,ANDA072235,"Teva Pharmaceuticals USA, Inc.",BACLOFEN,20,mg/1,"GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-5240,HUMAN PRESCRIPTION DRUG,Anagrelide Hydrochloride,,Anagrelide Hydrochloride,CAPSULE,ORAL,20050418,,ANDA,ANDA076468,"Teva Pharmaceuticals USA, Inc.",ANAGRELIDE HYDROCHLORIDE,1,mg/1,"Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-5241,HUMAN PRESCRIPTION DRUG,Anagrelide Hydrochloride,,Anagrelide Hydrochloride,CAPSULE,ORAL,20050418,,ANDA,ANDA076468,"Teva Pharmaceuticals USA, Inc.",ANAGRELIDE HYDROCHLORIDE,0.5,mg/1,"Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-5728,HUMAN PRESCRIPTION DRUG,Famotidine,,Famotidine,"TABLET, FILM COATED",ORAL,20010416,,ANDA,ANDA075511,"Teva Pharmaceuticals USA, Inc.",FAMOTIDINE,20,mg/1,"Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-5729,HUMAN PRESCRIPTION DRUG,Famotidine,,Famotidine,"TABLET, FILM COATED",ORAL,20010416,,ANDA,ANDA075511,"Teva Pharmaceuticals USA, Inc.",FAMOTIDINE,40,mg/1,"Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-6406,HUMAN PRESCRIPTION DRUG,Cromolyn Sodium,,Cromolyn Sodium,SOLUTION,INTRABRONCHIAL,20000118,,ANDA,ANDA075271,"Teva Pharmaceuticals USA, Inc.",CROMOLYN SODIUM,20,mg/2mL,"Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0172-7313,HUMAN PRESCRIPTION DRUG,Cyclosporine,,Cyclosporine,SOLUTION,ORAL,20050329,,ANDA,ANDA065078,"Teva Pharmaceuticals USA, Inc.",CYCLOSPORINE,100,mg/mL,"Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0135,HUMAN PRESCRIPTION DRUG,WELLBUTRIN,SR,bupropion hydrochloride,"TABLET, FILM COATED",ORAL,19961115,,NDA,NDA020358,GlaxoSmithKline LLC,BUPROPION HYDROCHLORIDE,150,mg/1,"Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0478,HUMAN PRESCRIPTION DRUG,IMITREX,,sumatriptan,INJECTION,SUBCUTANEOUS,19970127,,NDA,NDA020080,GlaxoSmithKline LLC,SUMATRIPTAN SUCCINATE,6,mg/.5mL,"Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0479,HUMAN PRESCRIPTION DRUG,IMITREX,,sumatriptan,INJECTION,SUBCUTANEOUS,19970123,,NDA,NDA020080,GlaxoSmithKline LLC,SUMATRIPTAN SUCCINATE,6,mg/.5mL,"Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0517,HUMAN PRESCRIPTION DRUG,FLOLAN,,epoprostenol sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19951208,,NDA,NDA020444,GlaxoSmithKline LLC,EPOPROSTENOL SODIUM,0.5,mg/1,"Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0519,HUMAN PRESCRIPTION DRUG,FLOLAN,,epoprostenol sodium,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,19951208,,NDA,NDA020444,GlaxoSmithKline LLC,EPOPROSTENOL SODIUM,1.5,mg/1,"Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0521,HUMAN PRESCRIPTION DRUG,SEREVENT,DISKUS,salmeterol xinafoate,"POWDER, METERED",ORAL; RESPIRATORY (INHALATION),19971125,,NDA,NDA020692,GlaxoSmithKline LLC,SALMETEROL XINAFOATE,50,ug/1,"Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0524,HUMAN PRESCRIPTION DRUG,IMITREX,,sumatriptan,SPRAY,NASAL,19971010,20250731,NDA,NDA020626,GlaxoSmithKline LLC,SUMATRIPTAN,5,mg/1,"Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0526,HUMAN PRESCRIPTION DRUG,LAMICTAL,,lamotrigine,"TABLET, FOR SUSPENSION",ORAL,19980904,,NDA,NDA020764,GlaxoSmithKline LLC,LAMOTRIGINE,5,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0527,HUMAN PRESCRIPTION DRUG,LAMICTAL,,lamotrigine,"TABLET, FOR SUSPENSION",ORAL,19980903,,NDA,NDA020764,GlaxoSmithKline LLC,LAMOTRIGINE,25,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0547,HUMAN PRESCRIPTION DRUG,MEPRON,,atovaquone,SUSPENSION,ORAL,19980918,,NDA,NDA020500,GlaxoSmithKline LLC,ATOVAQUONE,750,mg/5mL,"Antimalarial [EPC], Antiprotozoal [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0565,HUMAN PRESCRIPTION DRUG,VALTREX,,valacyclovir hydrochloride,"TABLET, FILM COATED",ORAL,20020812,,NDA,NDA020487,GlaxoSmithKline LLC,VALACYCLOVIR HYDROCHLORIDE,1,g/1,"DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0594,HUMAN PRESCRIPTION DRUG,LAMICTAL,,lamotrigine,KIT,,20030929,,NDA,NDA020241,GlaxoSmithKline LLC,,,,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0601,HUMAN PRESCRIPTION DRUG,FLOVENT,DISKUS,fluticasone propionate,"POWDER, METERED",RESPIRATORY (INHALATION),20081013,20250831,NDA,NDA020833,GlaxoSmithKline LLC,FLUTICASONE PROPIONATE,250,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0633,HUMAN PRESCRIPTION DRUG,LAMICTAL,,lamotrigine,TABLET,ORAL,19960815,,NDA,NDA020241,GlaxoSmithKline LLC,LAMOTRIGINE,25,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0642,HUMAN PRESCRIPTION DRUG,LAMICTAL,,lamotrigine,TABLET,ORAL,19950117,,NDA,NDA020241,GlaxoSmithKline LLC,LAMOTRIGINE,100,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0643,HUMAN PRESCRIPTION DRUG,LAMICTAL,,lamotrigine,TABLET,ORAL,19950117,,NDA,NDA020241,GlaxoSmithKline LLC,LAMOTRIGINE,150,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0644,HUMAN PRESCRIPTION DRUG,LAMICTAL,,lamotrigine,TABLET,ORAL,19950118,,NDA,NDA020241,GlaxoSmithKline LLC,LAMOTRIGINE,200,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0665,HUMAN PRESCRIPTION DRUG,MEPRON,,atovaquone,SUSPENSION,ORAL,19950228,,NDA,NDA020500,GlaxoSmithKline LLC,ATOVAQUONE,750,mg/5mL,"Antimalarial [EPC], Antiprotozoal [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0675,HUMAN PRESCRIPTION DRUG,MALARONE,,atovaquone and proguanil hydrochloride,"TABLET, FILM COATED",ORAL,20000726,,NDA,NDA021078,GlaxoSmithKline LLC,ATOVAQUONE; PROGUANIL HYDROCHLORIDE,250; 100,mg/1; mg/1,"Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0676,HUMAN PRESCRIPTION DRUG,MALARONE,,atovaquone and proguanil hydrochloride,"TABLET, FILM COATED",ORAL,20000726,,NDA,NDA021078,GlaxoSmithKline LLC,ATOVAQUONE; PROGUANIL HYDROCHLORIDE,62.5; 25,mg/1; mg/1,"Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0681,HUMAN PRESCRIPTION DRUG,RELENZA,,zanamivir,POWDER,RESPIRATORY (INHALATION),19990922,,NDA,NDA021036,GlaxoSmithKline LLC,ZANAMIVIR,5,mg/1,"Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0682,HUMAN PRESCRIPTION DRUG,VENTOLIN,HFA,albuterol sulfate,"AEROSOL, METERED",RESPIRATORY (INHALATION),20060609,,NDA,NDA020983,GlaxoSmithKline LLC,ALBUTEROL SULFATE,90,ug/1,"Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]",,N,20261231,J45.9,"[{""icd10_code"":""J45.9"",""description"":""Asthma, unspecified"",""confidence"":0.7,""context"":""asthma rescue""},{""icd10_code"":""J44.1"",""description"":""Chronic obstructive pulmonary disease with acute exacerbation"",""confidence"":0.2,""context"":""COPD exacerbation""},{""icd10_code"":""J44.0"",""description"":""Chronic obstructive pulmonary disease with acute lower respiratory infection"",""confidence"":0.1,""context"":""COPD with infection""}]",0.70
0173-0695,HUMAN PRESCRIPTION DRUG,ADVAIR,DISKUS,fluticasone propionate and salmeterol,POWDER,RESPIRATORY (INHALATION),20010228,,NDA,NDA021077,GlaxoSmithKline LLC,FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE,100; 50,ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0696,HUMAN PRESCRIPTION DRUG,ADVAIR,DISKUS,fluticasone propionate and salmeterol,POWDER,RESPIRATORY (INHALATION),20010205,,NDA,NDA021077,GlaxoSmithKline LLC,FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE,250; 50,ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0697,HUMAN PRESCRIPTION DRUG,ADVAIR,DISKUS,fluticasone propionate and salmeterol,POWDER,RESPIRATORY (INHALATION),20010305,,NDA,NDA021077,GlaxoSmithKline LLC,FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE,500; 50,ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0699,HUMAN PRESCRIPTION DRUG,LAMICTAL,,lamotrigine,"TABLET, FOR SUSPENSION",ORAL,20001012,,NDA,NDA020764,GlaxoSmithKline LLC,LAMOTRIGINE,2,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0715,HUMAN PRESCRIPTION DRUG,ADVAIR HFA,,fluticasone propionate and salmeterol xinafoate,"AEROSOL, METERED",RESPIRATORY (INHALATION),20080929,,NDA,NDA021254,GlaxoSmithKline LLC,FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE,45; 21,ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0716,HUMAN PRESCRIPTION DRUG,ADVAIR HFA,,fluticasone propionate and salmeterol xinafoate,"AEROSOL, METERED",RESPIRATORY (INHALATION),20080929,,NDA,NDA021254,GlaxoSmithKline LLC,FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE,115; 21,ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0717,HUMAN PRESCRIPTION DRUG,ADVAIR HFA,,fluticasone propionate and salmeterol xinafoate,"AEROSOL, METERED",RESPIRATORY (INHALATION),20090306,,NDA,NDA021254,GlaxoSmithKline LLC,FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE,230; 21,ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0718,HUMAN PRESCRIPTION DRUG,FLOVENT,HFA,fluticasone propionate,"AEROSOL, METERED",RESPIRATORY (INHALATION),20070406,20250630,NDA,NDA021433,GlaxoSmithKline LLC,FLUTICASONE PROPIONATE,44,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0719,HUMAN PRESCRIPTION DRUG,FLOVENT,HFA,fluticasone propionate,"AEROSOL, METERED",RESPIRATORY (INHALATION),20070129,20250630,NDA,NDA021433,GlaxoSmithKline LLC,FLUTICASONE PROPIONATE,110,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0720,HUMAN PRESCRIPTION DRUG,FLOVENT,HFA,fluticasone propionate,"AEROSOL, METERED",RESPIRATORY (INHALATION),20070125,20250731,NDA,NDA021433,GlaxoSmithKline LLC,FLUTICASONE PROPIONATE,220,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0722,HUMAN PRESCRIPTION DRUG,WELLBUTRIN,SR,bupropion hydrochloride,"TABLET, FILM COATED",ORAL,20020625,,NDA,NDA020358,GlaxoSmithKline LLC,BUPROPION HYDROCHLORIDE,200,mg/1,"Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0735,HUMAN PRESCRIPTION DRUG,IMITREX,,sumatriptan,"TABLET, FILM COATED",ORAL,20031217,,NDA,NDA020132,GlaxoSmithKline LLC,SUMATRIPTAN SUCCINATE,25,mg/1,"Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0736,HUMAN PRESCRIPTION DRUG,IMITREX,,sumatriptan,"TABLET, FILM COATED",ORAL,20031217,,NDA,NDA020132,GlaxoSmithKline LLC,SUMATRIPTAN SUCCINATE,50,mg/1,"Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0737,HUMAN PRESCRIPTION DRUG,IMITREX,,sumatriptan,"TABLET, FILM COATED",ORAL,20031219,,NDA,NDA020132,GlaxoSmithKline LLC,SUMATRIPTAN SUCCINATE,100,mg/1,"Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0739,HUMAN PRESCRIPTION DRUG,IMITREX,,sumatriptan,INJECTION,SUBCUTANEOUS,20060406,,NDA,NDA020080,GlaxoSmithKline LLC,SUMATRIPTAN SUCCINATE,4,mg/.5mL,"Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0754,HUMAN PRESCRIPTION DRUG,LAMICTAL,XR,lamotrigine,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20090706,,NDA,NDA022115,GlaxoSmithKline LLC,LAMOTRIGINE,25,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0755,HUMAN PRESCRIPTION DRUG,LAMICTAL,XR,lamotrigine,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20090706,,NDA,NDA022115,GlaxoSmithKline LLC,LAMOTRIGINE,50,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0756,HUMAN PRESCRIPTION DRUG,LAMICTAL,XR,lamotrigine,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20090706,,NDA,NDA022115,GlaxoSmithKline LLC,LAMOTRIGINE,100,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0757,HUMAN PRESCRIPTION DRUG,LAMICTAL,XR,lamotrigine,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20090706,,NDA,NDA022115,GlaxoSmithKline LLC,LAMOTRIGINE,200,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0758,HUMAN PRESCRIPTION DRUG,LAMICTAL,XR,lamotrigine,KIT,,20090706,,NDA,NDA022115,GlaxoSmithKline LLC,,,,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0759,HUMAN PRESCRIPTION DRUG,LAMICTAL,XR,lamotrigine,KIT,,20090706,,NDA,NDA022115,GlaxoSmithKline LLC,,,,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0760,HUMAN PRESCRIPTION DRUG,LAMICTAL,XR,lamotrigine,KIT,,20090706,,NDA,NDA022115,GlaxoSmithKline LLC,,,,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0761,HUMAN PRESCRIPTION DRUG,LAMICTAL,XR,lamotrigine,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20110331,,NDA,NDA022115,GlaxoSmithKline LLC,LAMOTRIGINE,300,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0772,HUMAN PRESCRIPTION DRUG,LAMICTAL,ODT,lamotrigine,"TABLET, ORALLY DISINTEGRATING",ORAL,20090605,,NDA,NDA022251,GlaxoSmithKline LLC,LAMOTRIGINE,25,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0774,HUMAN PRESCRIPTION DRUG,LAMICTAL,ODT,lamotrigine,"TABLET, ORALLY DISINTEGRATING",ORAL,20090605,,NDA,NDA022251,GlaxoSmithKline LLC,LAMOTRIGINE,50,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0776,HUMAN PRESCRIPTION DRUG,LAMICTAL,ODT,lamotrigine,"TABLET, ORALLY DISINTEGRATING",ORAL,20090605,,NDA,NDA022251,GlaxoSmithKline LLC,LAMOTRIGINE,100,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0777,HUMAN PRESCRIPTION DRUG,LAMICTAL,ODT,lamotrigine,"TABLET, ORALLY DISINTEGRATING",ORAL,20090605,,NDA,NDA022251,GlaxoSmithKline LLC,LAMOTRIGINE,200,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0778,HUMAN PRESCRIPTION DRUG,LAMICTAL,ODT,lamotrigine,KIT,,20090605,,NDA,NDA022251,GlaxoSmithKline LLC,,,,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0779,HUMAN PRESCRIPTION DRUG,LAMICTAL,ODT,lamotrigine,KIT,,20090605,,NDA,NDA022251,GlaxoSmithKline LLC,,,,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0780,HUMAN PRESCRIPTION DRUG,LAMICTAL,ODT,lamotrigine,KIT,,20090605,,NDA,NDA022251,GlaxoSmithKline LLC,,,,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0781,HUMAN PRESCRIPTION DRUG,LAMICTAL,XR,lamotrigine,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,20110815,,NDA,NDA022115,GlaxoSmithKline LLC,LAMOTRIGINE,250,mg/1,"Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0817,HUMAN PRESCRIPTION DRUG,LAMICTAL,,lamotrigine,KIT,,20030929,,NDA,NDA020241,GlaxoSmithKline LLC,,,,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0857,HUMAN PRESCRIPTION DRUG,Diluent,,water,SOLUTION,INTRAVENOUS,20160401,,NDA,NDA020444,GlaxoSmithKline LLC,WATER,1,mL/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0859,HUMAN PRESCRIPTION DRUG,Breo Ellipta,,fluticasone furoate and vilanterol trifenatate,POWDER,RESPIRATORY (INHALATION),20130826,,NDA,NDA204275,GlaxoSmithKline LLC,FLUTICASONE FUROATE; VILANTEROL TRIFENATATE,100; 25,ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0869,HUMAN PRESCRIPTION DRUG,Anoro Ellipta,,umeclidinium bromide and vilanterol trifenatate,POWDER,RESPIRATORY (INHALATION),20140131,,NDA,NDA203975,GlaxoSmithKline LLC,UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE,62.5; 25,ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0873,HUMAN PRESCRIPTION DRUG,Incruse Ellipta,,umeclidinium,"AEROSOL, POWDER",ORAL,20140430,,NDA,NDA205382,GlaxoSmithKline LLC,UMECLIDINIUM BROMIDE,62.5,ug/1,"Anticholinergic [EPC], Cholinergic Antagonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0874,HUMAN PRESCRIPTION DRUG,Arnuity Ellipta,,fluticasone furoate,POWDER,RESPIRATORY (INHALATION),20140820,,NDA,NDA205625,GlaxoSmithKline LLC,FLUTICASONE FUROATE,100,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0876,HUMAN PRESCRIPTION DRUG,Arnuity Ellipta,,fluticasone furoate,POWDER,RESPIRATORY (INHALATION),20140820,,NDA,NDA205625,GlaxoSmithKline LLC,FLUTICASONE FUROATE,200,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0881,HUMAN PRESCRIPTION DRUG,Nucala,,mepolizumab,"INJECTION, POWDER, FOR SOLUTION",SUBCUTANEOUS,20151104,,BLA,BLA125526,GlaxoSmithKline LLC,MEPOLIZUMAB,100,mg/mL,"Interleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0882,HUMAN PRESCRIPTION DRUG,Breo Ellipta,,fluticasone furoate and vilanterol trifenatate,POWDER,RESPIRATORY (INHALATION),20150430,,NDA,NDA204275,GlaxoSmithKline LLC,FLUTICASONE FUROATE; VILANTEROL TRIFENATATE,200; 25,ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0887,HUMAN PRESCRIPTION DRUG,Trelegy Ellipta,,"fluticasone furoate, umeclidinium bromide and vilanterol trifenatate",POWDER,RESPIRATORY (INHALATION),20170918,,NDA,NDA209482,GlaxoSmithKline LLC,FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE,100; 62.5; 25,ug/1; ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0888,HUMAN PRESCRIPTION DRUG,Arnuity Ellipta,,fluticasone furoate,POWDER,RESPIRATORY (INHALATION),20180517,,NDA,NDA205625,GlaxoSmithKline LLC,FLUTICASONE FUROATE,50,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0889,HUMAN PRESCRIPTION DRUG,Krintafel,,tafenoquine succinate,"TABLET, FILM COATED",ORAL,20190122,,NDA,NDA210795,GlaxoSmithKline LLC,TAFENOQUINE SUCCINATE,150,mg/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0892,HUMAN PRESCRIPTION DRUG,Nucala,,mepolizumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20190606,,BLA,BLA761122,GlaxoSmithKline LLC,MEPOLIZUMAB,100,mg/mL,"Interleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0893,HUMAN PRESCRIPTION DRUG,Trelegy Ellipta,,"fluticasone furoate, umeclidinium bromide and vilanterol trifenatate",POWDER,RESPIRATORY (INHALATION),20200909,,NDA,NDA209482,GlaxoSmithKline LLC,FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE,200; 62.5; 25,ug/1; ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0897,HUMAN PRESCRIPTION DRUG,Jesduvroq,,daprodustat,"TABLET, FILM COATED",ORAL,20230201,20270131,NDA,NDA216951,GlaxoSmithKline LLC,DAPRODUSTAT,1,mg/1,"Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA], Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0898,HUMAN PRESCRIPTION DRUG,Jemperli,,dostarlimab,INJECTION,INTRAVENOUS,20210422,,BLA,BLA761174,GlaxoSmithKline LLC,DOSTARLIMAB,50,mg/mL,"Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0903,HUMAN PRESCRIPTION DRUG,Jesduvroq,,daprodustat,"TABLET, FILM COATED",ORAL,20230201,20270430,NDA,NDA216951,GlaxoSmithKline LLC,DAPRODUSTAT,2,mg/1,"Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA], Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0904,HUMAN PRESCRIPTION DRUG,Nucala,,mepolizumab,"INJECTION, SOLUTION",SUBCUTANEOUS,20220122,,BLA,BLA761122,GlaxoSmithKline LLC,MEPOLIZUMAB,40,mg/.4mL,"Interleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0906,HUMAN PRESCRIPTION DRUG,Jesduvroq,,daprodustat,"TABLET, FILM COATED",ORAL,20230201,20270430,NDA,NDA216951,GlaxoSmithKline LLC,DAPRODUSTAT,4,mg/1,"Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA], Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0909,HUMAN PRESCRIPTION DRUG,ZEJULA,,niraparib,"TABLET, FILM COATED",ORAL,20230627,,NDA,NDA214876,GlaxoSmithKline LLC,NIRAPARIB TOSYLATE,100,mg/1,"Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0911,HUMAN PRESCRIPTION DRUG,Jesduvroq,,daprodustat,"TABLET, FILM COATED",ORAL,20230201,20261130,NDA,NDA216951,GlaxoSmithKline LLC,DAPRODUSTAT,6,mg/1,"Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA], Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0912,HUMAN PRESCRIPTION DRUG,ZEJULA,,niraparib,"TABLET, FILM COATED",ORAL,20230627,,NDA,NDA214876,GlaxoSmithKline LLC,NIRAPARIB TOSYLATE,200,mg/1,"Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0914,HUMAN PRESCRIPTION DRUG,Jesduvroq,,daprodustat,"TABLET, FILM COATED",ORAL,20230201,20261130,NDA,NDA216951,GlaxoSmithKline LLC,DAPRODUSTAT,8,mg/1,"Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA], Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0915,HUMAN PRESCRIPTION DRUG,ZEJULA,,niraparib,"TABLET, FILM COATED",ORAL,20230627,,NDA,NDA214876,GlaxoSmithKline LLC,NIRAPARIB TOSYLATE,300,mg/1,"Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0916,HUMAN PRESCRIPTION DRUG,Breo Ellipta,,fluticasone furoate and vilanterol trifenatate,POWDER,RESPIRATORY (INHALATION),20230512,,NDA,NDA204275,GlaxoSmithKline LLC,FLUTICASONE FUROATE; VILANTEROL TRIFENATATE,50; 25,ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0922,HUMAN PRESCRIPTION DRUG,Blujepa,,gepotidacin,"TABLET, FILM COATED",ORAL,20250325,,NDA,NDA218230,GlaxoSmithKline LLC,GEPOTIDACIN MESYLATE,750,mg/1,,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0933,HUMAN PRESCRIPTION DRUG,VALTREX,,valacyclovir hydrochloride,"TABLET, FILM COATED",ORAL,19950801,,NDA,NDA020487,GlaxoSmithKline LLC,VALACYCLOVIR HYDROCHLORIDE,500,mg/1,"DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0173-0947,HUMAN PRESCRIPTION DRUG,WELLBUTRIN,SR,bupropion hydrochloride,"TABLET, FILM COATED",ORAL,19961115,,NDA,NDA020358,GlaxoSmithKline LLC,BUPROPION HYDROCHLORIDE,100,mg/1,"Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0089,HUMAN PRESCRIPTION DRUG,Ferralet 90,,"iron, folic acid, cyanocobalamin, ascorbic acid, and docusate sodium","TABLET, FILM COATED",ORAL,20100204,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,ASCORBIC ACID; CYANOCOBALAMIN; DOCUSATE SODIUM; FOLIC ACID; IRON,120; 12; 50; 1; 90,mg/1; ug/1; mg/1; mg/1; mg/1,"Ascorbic Acid [CS], Vitamin B 12 [CS], Vitamin B12 [EPC], Vitamin C [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0314,HUMAN OTC DRUG,POTASSIUM IODIDE,,POTASSIUM IODIDE,SOLUTION,ORAL,20160515,,ANDA,ANDA206211,Mission Pharmacal Company,POTASSIUM IODIDE,65,mg/mL,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0320,HUMAN OTC DRUG,Theragesic,,METHYL SALICYLATE,CREAM,TOPICAL,19810101,,OTC MONOGRAPH DRUG,M017,Mission Pharmacal Company,MENTHOL; METHYL SALICYLATE,10; 150,mg/g; mg/g,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0330,HUMAN OTC DRUG,DR SMITHS DIAPER,,Zinc Oxide,OINTMENT,TOPICAL,20100301,,OTC MONOGRAPH DRUG,M016,Mission Pharmacal,ZINC OXIDE,100,mg/g,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0455,HUMAN PRESCRIPTION DRUG,Texacort,,Hydrocortisone,SOLUTION,TOPICAL,20111215,,ANDA,ANDA081271,Mission Pharmacal Company,HYDROCORTISONE,25,mg/mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0460,HUMAN PRESCRIPTION DRUG,Avar-e Green,,"SULFACETAMIDE SODIUM, SULFUR",CREAM,TOPICAL,20110915,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,SULFACETAMIDE SODIUM; SULFUR,100; 50,mg/g; mg/g,"Sulfonamide Antibacterial [EPC], Sulfonamides [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0465,HUMAN PRESCRIPTION DRUG,Avar-e LS,,"SULFACETAMIDE SODIUM, SULFUR",CREAM,TOPICAL,20110915,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,SULFACETAMIDE SODIUM; SULFUR,100; 20,mg/g; mg/g,"Sulfonamide Antibacterial [EPC], Sulfonamides [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0470,HUMAN PRESCRIPTION DRUG,Avar-e,,"SULFACETAMIDE SODIUM, SULFUR",CREAM,TOPICAL,20110915,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,SULFACETAMIDE SODIUM; SULFUR,100; 50,mg/g; mg/g,"Sulfonamide Antibacterial [EPC], Sulfonamides [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0475,HUMAN PRESCRIPTION DRUG,AVAR LS,,"SULFACETAMIDE SODIUM, SULFUR",EMULSION,TOPICAL,20110915,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,SULFACETAMIDE SODIUM; SULFUR,100; 20,mg/g; mg/g,"Sulfonamide Antibacterial [EPC], Sulfonamides [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0480,HUMAN PRESCRIPTION DRUG,AVAR,,"SULFACETAMIDE SODIUM, SULFUR",EMULSION,TOPICAL,20110915,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,SULFACETAMIDE SODIUM; SULFUR,100; 50,mg/g; mg/g,"Sulfonamide Antibacterial [EPC], Sulfonamides [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0485,HUMAN PRESCRIPTION DRUG,OVACE Plus,,SULFACETAMIDE SODIUM,SHAMPOO,TOPICAL,20110915,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,SULFACETAMIDE SODIUM,100,mg/mL,"Sulfonamide Antibacterial [EPC], Sulfonamides [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0490,HUMAN PRESCRIPTION DRUG,OVACE Plus,,SULFACETAMIDE SODIUM,LIQUID,TOPICAL,20110915,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,SULFACETAMIDE SODIUM,100,mg/mL,"Sulfonamide Antibacterial [EPC], Sulfonamides [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0495,HUMAN PRESCRIPTION DRUG,OvacePlus,Plus,SULFACETAMIDE SODIUM,CREAM,TOPICAL,20110915,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,SULFACETAMIDE SODIUM,100,mg/g,"Sulfonamide Antibacterial [EPC], Sulfonamides [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0499,HUMAN PRESCRIPTION DRUG,OVACE,,SULFACETAMIDE SODIUM,LIQUID,TOPICAL,20110915,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,SULFACETAMIDE SODIUM,100,mg/mL,"Sulfonamide Antibacterial [EPC], Sulfonamides [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0500,HUMAN PRESCRIPTION DRUG,Lithostat,,acetohydroxamic acid,TABLET,ORAL,19830531,,NDA,NDA018749,Mission Pharmacal Company,ACETOHYDROXAMIC ACID,250,mg/1,"Urease Inhibitor [EPC], Urease Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0600,HUMAN PRESCRIPTION DRUG,UROCIT-K,,potassium citrate,"TABLET, EXTENDED RELEASE",ORAL,19850901,,NDA,NDA019071,Mission Pharmacal Company,POTASSIUM CITRATE,5,meq/1,"Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0610,HUMAN PRESCRIPTION DRUG,UROCIT-K,,potassium citrate,"TABLET, EXTENDED RELEASE",ORAL,19920901,,NDA,NDA019071,Mission Pharmacal Company,POTASSIUM CITRATE,10,meq/1,"Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0615,HUMAN PRESCRIPTION DRUG,UROCIT-K,,potassium citrate,"TABLET, EXTENDED RELEASE",ORAL,20100127,,NDA,NDA019071,Mission Pharmacal Company,POTASSIUM CITRATE,15,meq/1,"Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0620,HUMAN PRESCRIPTION DRUG,Ovace,Plus,SULFACETAMIDE SODIUM,LOTION,TOPICAL,20110915,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,SULFACETAMIDE SODIUM,98,mg/g,"Sulfonamide Antibacterial [EPC], Sulfonamides [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0630,HUMAN PRESCRIPTION DRUG,OVACE,PLUS,SODIUM SULFACETAMIDE,LIQUID,TOPICAL,20110907,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,SULFACETAMIDE SODIUM,100,mg/mL,"Sulfonamide Antibacterial [EPC], Sulfonamides [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0178-0745,HUMAN PRESCRIPTION DRUG,URIBEL TABS,,"Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate","TABLET, COATED",ORAL,20231107,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,BENZOIC ACID; HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE,9; .12; 81.6; 10.8; 36.2,mg/1; mg/1; mg/1; mg/1; mg/1,"Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0796,HUMAN PRESCRIPTION DRUG,CitraNatal Harmony 3.0,,"Calcium citrate, Iron pentacarbonyl, Cholecalciferol, .Alpha.-Tocopherol, Dl-, Pyridoxine hydrochloride, Folic Acid, Docusate Sodium, and Doconexent","CAPSULE, GELATIN COATED",ORAL,20140321,20251130,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,.ALPHA.-TOCOPHEROL; CALCIUM CITRATE; CHOLECALCIFEROL; DOCONEXENT; DOCUSATE SODIUM; FOLIC ACID; IRON; PYRIDOXINE,30; 104; 400; 260; 50; 1; 27; 25,[iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1,"Analogs/Derivatives [Chemical/Ingredient], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin D [CS], Vitamin D [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0821,HUMAN PRESCRIPTION DRUG,CitraNatal 90 DHA,,"Vitamin C, Calcium, Iron, Vitamin D3, Vitamin E, Thiamin, Riboflavin, Niacinamide, Vitamin B6, Folic Acid, Iodine, Zinc, Copper, Docusate Sodium",TABLET,ORAL,20140411,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; CALCIUM CITRATE; CUPRIC OXIDE; DOCUSATE SODIUM; FERROUS GLUCONATE; FOLIC ACID; IRON; NIACINAMIDE; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE; THIAMINE MONONITRATE; VITAMIN D; ZINC OXIDE,30; 120; 159; 2; 50; 5; 1; 85; 20; 150; 20; 3.4; 3; 4.54; 400; 25,[iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; mg/1,"Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0891,HUMAN PRESCRIPTION DRUG,CitraNatal Assure,,"ascorbic acid, calcium citrate, iron, vitamin d, dl- alpha- tocopherol acetate, thiamine, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, iodine, zinc, copper, docusate sodium, doconexent and icosapent",KIT,,20140430,,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0896,HUMAN PRESCRIPTION DRUG,CitraNatal Medley,,"Calcium citrate, Iron pentacarbonyl, Ferrous Fumarate, Cholecalciferol, .Alpha.-Tocopherol, Dl-, Pyridoxine hydrochloride, Folic Acid, and Doconexent","CAPSULE, GELATIN COATED",ORAL,20180320,20251130,UNAPPROVED DRUG OTHER,,Mission Pharmacal Company,.ALPHA.-TOCOPHEROL; CALCIUM CITRATE; CHOLECALCIFEROL; DOCONEXENT; FERROUS FUMARATE; FOLIC ACID; IRON; PYRIDOXINE,15; 62; 200; 200; 2; 1; 27; 12.5,[iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1,"Analogs/Derivatives [Chemical/Ingredient], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin D [CS], Vitamin D [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0900,HUMAN PRESCRIPTION DRUG,Thiola,,tiopronin,"TABLET, SUGAR COATED",ORAL,19880811,,NDA,NDA019569,Mission Pharmacal Company,TIOPRONIN,100,mg/1,"Cystine Disulfide Reduction [MoA], N-substituted Glycines [CS], Reducing and Complexing Thiol [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0901,HUMAN PRESCRIPTION DRUG,Thiola EC,,tiopronin,"TABLET, DELAYED RELEASE",ORAL,20190628,,NDA,NDA211843,Mission Pharmacal Company,TIOPRONIN,300,mg/1,"Cystine Disulfide Reduction [MoA], N-substituted Glycines [CS], Reducing and Complexing Thiol [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-0902,HUMAN PRESCRIPTION DRUG,Thiola EC,,tiopronin,"TABLET, DELAYED RELEASE",ORAL,20190628,,NDA,NDA211843,Mission Pharmacal Company,TIOPRONIN,100,mg/1,"Cystine Disulfide Reduction [MoA], N-substituted Glycines [CS], Reducing and Complexing Thiol [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-8250,HUMAN PRESCRIPTION DRUG,Tindamax,,tinidazole,"TABLET, FILM COATED",ORAL,20040517,,NDA,NDA021618,Mission Pharmacal Company,TINIDAZOLE,250,mg/1,"Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0178-8500,HUMAN PRESCRIPTION DRUG,Tindamax,,tinidazole,"TABLET, FILM COATED",ORAL,20040517,,NDA,NDA021618,Mission Pharmacal Company,TINIDAZOLE,500,mg/1,"Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0022,HUMAN PRESCRIPTION DRUG,Orphenadrine Citrate,,Orphenadrine Citrate,"TABLET, EXTENDED RELEASE",ORAL,20000215,20270320,ANDA,ANDA040327,Sandoz Inc,ORPHENADRINE CITRATE,100,mg/1,"Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0055,HUMAN PRESCRIPTION DRUG,Metolazone,,Metolazone,TABLET,ORAL,20031219,,ANDA,ANDA076466,Sandoz Inc,METOLAZONE,5,mg/1,"Increased Diuresis [PE], Thiazide-like Diuretic [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0122,HUMAN PRESCRIPTION DRUG,Nitrofurantoin (monohydrate/macrocrystals),,Nitrofurantoin (monohydrate/macrocrystals),CAPSULE,ORAL,20050406,,ANDA,ANDA077066,Sandoz Inc,NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE,25; 75,mg/1; mg/1,"Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0128,HUMAN PRESCRIPTION DRUG,Bumetanide,,Bumetanide,TABLET,ORAL,19961121,,ANDA,ANDA074700,Sandoz Inc,BUMETANIDE,0.5,mg/1,"Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0129,HUMAN PRESCRIPTION DRUG,Bumetanide,,Bumetanide,TABLET,ORAL,19961121,,ANDA,ANDA074700,Sandoz Inc,BUMETANIDE,1,mg/1,"Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0130,HUMAN PRESCRIPTION DRUG,Bumetanide,,Bumetanide,TABLET,ORAL,19961121,,ANDA,ANDA074700,Sandoz Inc,BUMETANIDE,2,mg/1,"Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0141,HUMAN PRESCRIPTION DRUG,Oxaprozin,,Oxaprozin,TABLET,ORAL,20010131,20250630,ANDA,ANDA075845,"Eon Labs, Inc.",OXAPROZIN,600,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0211,HUMAN PRESCRIPTION DRUG,Benazepril Hydrochloride and Hydrochlorothiazide,,Benazepril Hydrochloride and Hydrochlorothiazide,"TABLET, FILM COATED",ORAL,20040211,,ANDA,ANDA076631,Sandoz Inc,BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE,20; 12.5,mg/1; mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0236,HUMAN PRESCRIPTION DRUG,Benazepril Hydrochloride and Hydrochlorothiazide,,Benazepril Hydrochloride and Hydrochlorothiazide,"TABLET, FILM COATED",ORAL,20150317,,ANDA,ANDA076631,Sandoz Inc,BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE,5; 6.25,mg/1; mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0277,HUMAN PRESCRIPTION DRUG,Benazepril Hydrochloride and Hydrochlorothiazide,,Benazepril Hydrochloride and Hydrochlorothiazide,"TABLET, FILM COATED",ORAL,20040211,,ANDA,ANDA076631,Sandoz Inc,BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE,20; 25,mg/1; mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0325,HUMAN PRESCRIPTION DRUG,Benazepril Hydrochloride and Hydrochlorothiazide,,Benazepril Hydrochloride and Hydrochlorothiazide,"TABLET, FILM COATED",ORAL,20140404,,ANDA,ANDA076631,Sandoz Inc,BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE,10; 12.5,mg/1; mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0410,HUMAN PRESCRIPTION DRUG,Bupropion Hydrochloride,,Bupropion Hydrochloride,"TABLET, EXTENDED RELEASE",ORAL,20031125,20250731,ANDA,ANDA075932,"Eon Labs, Inc.",BUPROPION HYDROCHLORIDE,100,mg/1,"Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0415,HUMAN PRESCRIPTION DRUG,Bupropion Hydrochloride,,Bupropion Hydrochloride,"TABLET, EXTENDED RELEASE",ORAL,20040322,20250731,ANDA,ANDA075932,"Eon Labs, Inc.",BUPROPION HYDROCHLORIDE,150,mg/1,"Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0615,HUMAN PRESCRIPTION DRUG,hydroxyzine pamoate,,hydroxyzine pamoate,CAPSULE,ORAL,19811214,20260531,ANDA,ANDA086183,Sandoz Inc,HYDROXYZINE PAMOATE,50,mg/1,"Antihistamine [EPC], Histamine Receptor Antagonists [MoA]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0674,HUMAN PRESCRIPTION DRUG,hydroxyzine pamoate,,hydroxyzine pamoate,CAPSULE,ORAL,19811214,,ANDA,ANDA087479,Sandoz Inc,HYDROXYZINE PAMOATE,25,mg/1,"Antihistamine [EPC], Histamine Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0675,HUMAN PRESCRIPTION DRUG,Etodolac,,Etodolac,"TABLET, COATED",ORAL,20150420,20250731,ANDA,ANDA074903,"Eon Labs, Inc.",ETODOLAC,400,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0676,HUMAN PRESCRIPTION DRUG,Hydroxyzine pamoate,,Hydroxyzine Pamoate,CAPSULE,ORAL,19811214,,ANDA,ANDA086183,Sandoz Inc,HYDROXYZINE PAMOATE,50,mg/1,"Antihistamine [EPC], Histamine Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0687,HUMAN PRESCRIPTION DRUG,Etodolac,,Etodolac,"TABLET, COATED",ORAL,20150420,20250731,ANDA,ANDA074903,"Eon Labs, Inc.",ETODOLAC,500,mg/1,"Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0799,HUMAN PRESCRIPTION DRUG,Rifampin,,Rifampin,CAPSULE,ORAL,19970528,20250630,ANDA,ANDA064150,"Eon Labs, Inc.",RIFAMPIN,300,mg/1,"Rifamycin Antibacterial [EPC], Rifamycins [CS]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0801,HUMAN PRESCRIPTION DRUG,Rifampin,,Rifampin,CAPSULE,ORAL,19980102,20250630,ANDA,ANDA064150,"Eon Labs, Inc.",RIFAMPIN,150,mg/1,"Rifamycin Antibacterial [EPC], Rifamycins [CS]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0842,HUMAN PRESCRIPTION DRUG,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",TABLET,ORAL,20020614,,ANDA,ANDA040439,Sandoz Inc,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,2.5; 2.5; 2.5; 2.5,mg/1; mg/1; mg/1; mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0853,HUMAN PRESCRIPTION DRUG,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",TABLET,ORAL,20020614,,ANDA,ANDA040439,Sandoz Inc,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,5; 5; 5; 5,mg/1; mg/1; mg/1; mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0939,HUMAN PRESCRIPTION DRUG,cholestyramine light,,cholestyramine light,"POWDER, FOR SUSPENSION",ORAL,19941104,20250731,ANDA,ANDA074558,"Eon Labs, Inc.",CHOLESTYRAMINE,4,g/5.7g,"Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-0940,HUMAN PRESCRIPTION DRUG,Cholestyramine,,Cholestyramine,"POWDER, FOR SUSPENSION",ORAL,19960815,20250930,ANDA,ANDA074557,"Eon Labs, Inc.",CHOLESTYRAMINE,4,g/9g,"Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-1111,HUMAN PRESCRIPTION DRUG,Bupropion Hydrochloride,,Bupropion Hydrochloride,"TABLET, EXTENDED RELEASE",ORAL,20050622,20250731,ANDA,ANDA075932,"Eon Labs, Inc.",BUPROPION HYDROCHLORIDE,200,mg/1,"Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-2098,HUMAN PRESCRIPTION DRUG,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",TABLET,ORAL,20020614,,ANDA,ANDA040439,Sandoz Inc,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,1.25; 1.25; 1.25; 1.25,mg/1; mg/1; mg/1; mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-2099,HUMAN PRESCRIPTION DRUG,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",,"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",TABLET,ORAL,20020614,,ANDA,ANDA040439,Sandoz Inc,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,7.5; 7.5; 7.5; 7.5,mg/1; mg/1; mg/1; mg/1,"Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-5050,HUMAN PRESCRIPTION DRUG,Metolazone,,Metolazone,TABLET,ORAL,20031219,,ANDA,ANDA076732,Sandoz Inc,METOLAZONE,2.5,mg/1,"Increased Diuresis [PE], Thiazide-like Diuretic [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0185-5600,HUMAN PRESCRIPTION DRUG,Metolazone,,Metolazone,TABLET,ORAL,20031219,,ANDA,ANDA076466,Sandoz Inc,METOLAZONE,10,mg/1,"Increased Diuresis [PE], Thiazide-like Diuretic [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0186-0370,HUMAN PRESCRIPTION DRUG,SYMBICORT,,Budesonide and Formoterol Fumarate Dihydrate,AEROSOL,RESPIRATORY (INHALATION),20070529,,NDA,NDA021929,AstraZeneca Pharmaceuticals LP,BUDESONIDE; FORMOTEROL FUMARATE,160; 4.5,ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0186-0372,HUMAN PRESCRIPTION DRUG,SYMBICORT,,Budesonide and Formoterol Fumarate Dihydrate,AEROSOL,RESPIRATORY (INHALATION),20070529,,NDA,NDA021929,AstraZeneca Pharmaceuticals LP,BUDESONIDE; FORMOTEROL FUMARATE,80; 4.5,ug/1; ug/1,"Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0186-0776,HUMAN PRESCRIPTION DRUG,BRILINTA,,Ticagrelor,TABLET,ORAL,20150904,,NDA,NDA022433,AstraZeneca Pharmaceuticals LP,TICAGRELOR,60,mg/1,"Cytochrome P450 3A4 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0186-0777,HUMAN PRESCRIPTION DRUG,BRILINTA,,Ticagrelor,TABLET,ORAL,20110805,,NDA,NDA022433,AstraZeneca Pharmaceuticals LP,TICAGRELOR,90,mg/1,"Cytochrome P450 3A4 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0186-0916,HUMAN PRESCRIPTION DRUG,PULMICORT,FLEXHALER,Budesonide,"AEROSOL, POWDER",RESPIRATORY (INHALATION),20070319,20251031,NDA,NDA021949,AstraZeneca Pharmaceuticals LP,BUDESONIDE,180,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0186-0917,HUMAN PRESCRIPTION DRUG,PULMICORT,FLEXHALER,Budesonide,"AEROSOL, POWDER",RESPIRATORY (INHALATION),20070319,20251031,NDA,NDA021949,AstraZeneca Pharmaceuticals LP,BUDESONIDE,90,ug/1,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0186-1988,HUMAN PRESCRIPTION DRUG,PULMICORT RESPULES,,Budesonide,SUSPENSION,RESPIRATORY (INHALATION),20000908,,NDA,NDA020929,AstraZeneca Pharmaceuticals LP,BUDESONIDE,0.25,mg/2mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0186-1989,HUMAN PRESCRIPTION DRUG,PULMICORT RESPULES,,Budesonide,SUSPENSION,RESPIRATORY (INHALATION),20000908,,NDA,NDA020929,AstraZeneca Pharmaceuticals LP,BUDESONIDE,0.5,mg/2mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0186-1990,HUMAN PRESCRIPTION DRUG,PULMICORT RESPULES,,Budesonide,SUSPENSION,RESPIRATORY (INHALATION),20070917,,NDA,NDA020929,AstraZeneca Pharmaceuticals LP,BUDESONIDE,1,mg/2mL,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0186-4010,HUMAN PRESCRIPTION DRUG,NEXIUM,,Esomeprazole magnesium,"GRANULE, DELAYED RELEASE",ORAL,20080707,,NDA,NDA022101,AstraZeneca Pharmaceuticals LP,ESOMEPRAZOLE MAGNESIUM,10,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0186-4020,HUMAN PRESCRIPTION DRUG,NEXIUM,,Esomeprazole magnesium,"GRANULE, DELAYED RELEASE",ORAL,20070319,,NDA,NDA021957,AstraZeneca Pharmaceuticals LP,ESOMEPRAZOLE MAGNESIUM,20,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0186-4025,HUMAN PRESCRIPTION DRUG,NEXIUM,,Esomeprazole magnesium,"GRANULE, DELAYED RELEASE",ORAL,20120601,,NDA,NDA021957,AstraZeneca Pharmaceuticals LP,ESOMEPRAZOLE MAGNESIUM,2.5,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0186-4040,HUMAN PRESCRIPTION DRUG,NEXIUM,,Esomeprazole magnesium,"GRANULE, DELAYED RELEASE",ORAL,20070319,,NDA,NDA021957,AstraZeneca Pharmaceuticals LP,ESOMEPRAZOLE MAGNESIUM,40,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0186-4050,HUMAN PRESCRIPTION DRUG,NEXIUM,,Esomeprazole magnesium,"GRANULE, DELAYED RELEASE",ORAL,20120601,,NDA,NDA021957,AstraZeneca Pharmaceuticals LP,ESOMEPRAZOLE MAGNESIUM,5,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0186-5020,HUMAN PRESCRIPTION DRUG,NEXIUM,,Esomeprazole magnesium,"CAPSULE, DELAYED RELEASE",ORAL,20010319,,NDA,NDA021153,AstraZeneca Pharmaceuticals LP,ESOMEPRAZOLE MAGNESIUM,20,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0186-5040,HUMAN PRESCRIPTION DRUG,NEXIUM,,Esomeprazole magnesium,"CAPSULE, DELAYED RELEASE",ORAL,20010319,,NDA,NDA021153,AstraZeneca Pharmaceuticals LP,ESOMEPRAZOLE MAGNESIUM,40,mg/1,"Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]",,N,20251231,K21.9,"[{""icd10_code"":""K21.9"",""description"":""Gastro-esophageal reflux disease without esophagitis"",""confidence"":0.5,""context"":""GERD""},{""icd10_code"":""K25.9"",""description"":""Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.25,""context"":""gastric ulcer""},{""icd10_code"":""K27.9"",""description"":""Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation"",""confidence"":0.15,""context"":""peptic ulcer""},{""icd10_code"":""K30"",""description"":""Functional dyspepsia"",""confidence"":0.1,""context"":""dyspepsia""}]",0.50
0187-0002,HUMAN PRESCRIPTION DRUG,Bryhali,,halobetasol propionate,LOTION,TOPICAL,20181106,,NDA,NDA209355,"Bausch Health US, LLC",HALOBETASOL PROPIONATE,0.1,mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-0004,HUMAN PRESCRIPTION DRUG,Siliq,,Brodalumab,INJECTION,SUBCUTANEOUS,20170215,,BLA,BLA761032,Bausch Health US LLC,BRODALUMAB,210,mg/1,"Antibodies, Monoclonal [CS], Interleukin 17 Receptor A Antagonists [MoA], Interleukin-17 Receptor A Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0005,HUMAN PRESCRIPTION DRUG,Altreno,,tretinoin,LOTION,TOPICAL,20180824,,NDA,NDA209353,"Bausch Health US, LLC",TRETINOIN,0.5,mg/g,"Retinoid [EPC], Retinoids [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-0006,HUMAN PRESCRIPTION DRUG,Cabtreo,,clindamycin phosphate/benzoyl peroxide/adapalene,GEL,TOPICAL,20231020,,NDA,NDA216632,Bausch Health US LLC,ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE,1.5; 31; 12,mg/g; mg/g; mg/g,"Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE], Retinoid [EPC], Retinoids [CS]",,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-0007,HUMAN PRESCRIPTION DRUG,Virazole,,Ribavirin,"POWDER, FOR SOLUTION",RESPIRATORY (INHALATION),19860101,,NDA,NDA018859,"Bausch Health US, LLC",RIBAVIRIN,6,g/1,"Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0010,HUMAN PRESCRIPTION DRUG,Ammonul,,sodium phenylacetate and sodium benzoate,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,20050217,20250630,NDA,NDA020645,Bausch Health US LLC,SODIUM BENZOATE; SODIUM PHENYLACETATE,100; 100,mg/mL; mg/mL,"Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]",,N,,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0063,HUMAN PRESCRIPTION DRUG,Ativan,,lorazepam,TABLET,ORAL,20130501,,NDA,NDA017794,Bausch Health US LLC,LORAZEPAM,0.5,mg/1,"Benzodiazepine [EPC], Benzodiazepines [CS]",CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0064,HUMAN PRESCRIPTION DRUG,Ativan,,lorazepam,TABLET,ORAL,20130501,,NDA,NDA017794,Bausch Health US LLC,LORAZEPAM,1,mg/1,"Benzodiazepine [EPC], Benzodiazepines [CS]",CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0065,HUMAN PRESCRIPTION DRUG,Ativan,,lorazepam,TABLET,ORAL,20130501,,NDA,NDA017794,Bausch Health US LLC,LORAZEPAM,2,mg/1,"Benzodiazepine [EPC], Benzodiazepines [CS]",CIV,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0140,HUMAN PRESCRIPTION DRUG,Vasotec,,Enalapril Maleate,TABLET,ORAL,19880726,,NDA,NDA018998,Bausch Health US LLC,ENALAPRIL MALEATE,2.5,mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0141,HUMAN PRESCRIPTION DRUG,Vasotec,,Enalapril Maleate,TABLET,ORAL,19851224,,NDA,NDA018998,Bausch Health US LLC,ENALAPRIL MALEATE,5,mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0142,HUMAN PRESCRIPTION DRUG,Vasotec,,Enalapril Maleate,TABLET,ORAL,19851224,,NDA,NDA018998,Bausch Health US LLC,ENALAPRIL MALEATE,10,mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0143,HUMAN PRESCRIPTION DRUG,Vasotec,,Enalapril Maleate,TABLET,ORAL,19851224,,NDA,NDA018998,Bausch Health US LLC,ENALAPRIL MALEATE,20,mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0146,HUMAN PRESCRIPTION DRUG,Vaseretic,,enalapril maleate and hydrochlorothiazide,TABLET,ORAL,19861031,,NDA,NDA019221,"Bausch Health US, LLC",ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE,10; 25,mg/1; mg/1,"Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0152,HUMAN PRESCRIPTION DRUG,Isordil,Titradose,isosorbide dinitrate,TABLET,ORAL,20130401,,NDA,NDA012093,Bausch Health US LLC,ISOSORBIDE DINITRATE,5,mg/1,"Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0192,HUMAN PRESCRIPTION DRUG,Isordil,Titradose,isosorbide dinitrate,TABLET,ORAL,20130401,,NDA,NDA012093,Bausch Health US LLC,ISOSORBIDE DINITRATE,40,mg/1,"Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0453,HUMAN PRESCRIPTION DRUG,ZELAPAR,,SELEGILINE HYDROCHLORIDE,"TABLET, ORALLY DISINTEGRATING",ORAL,20060614,,NDA,NDA021479,"Bausch Health US, LLC",SELEGILINE HYDROCHLORIDE,1.25,mg/1,"Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0653,HUMAN PRESCRIPTION DRUG,Duobrii,,halobetasol propionate and tazarotene,LOTION,TOPICAL,20190425,,NDA,NDA209354,"Bausch Health US, LLC",HALOBETASOL PROPIONATE; TAZAROTENE,.1; .45,mg/g; mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Retinoid [EPC], Retinoids [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-0730,HUMAN PRESCRIPTION DRUG,WELLBUTRIN,XL,bupropion hydrochloride,"TABLET, EXTENDED RELEASE",ORAL,20030829,,NDA,NDA021515,Bausch Health US LLC,BUPROPION HYDROCHLORIDE,150,mg/1,"Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0731,HUMAN PRESCRIPTION DRUG,WELLBUTRIN,XL,bupropion hydrochloride,"TABLET, EXTENDED RELEASE",ORAL,20030829,,NDA,NDA021515,Bausch Health US LLC,BUPROPION HYDROCHLORIDE,300,mg/1,"Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0771,HUMAN PRESCRIPTION DRUG,Cardizem,,Diltiazem Hydrochloride,"TABLET, COATED",ORAL,20101225,,NDA,NDA018602,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,30,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0772,HUMAN PRESCRIPTION DRUG,Cardizem,,Diltiazem Hydrochloride,"TABLET, COATED",ORAL,20101225,,NDA,NDA018602,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,60,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0792,HUMAN PRESCRIPTION DRUG,Cardizem,,Diltiazem Hydrochloride,"TABLET, COATED",ORAL,20101225,,NDA,NDA018602,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,120,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0795,HUMAN PRESCRIPTION DRUG,Cardizem CD,,diltiazem hydrochloride,"CAPSULE, COATED, EXTENDED RELEASE",ORAL,20010411,,NDA,NDA020062,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,120,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0796,HUMAN PRESCRIPTION DRUG,Cardizem CD,,diltiazem hydrochloride,"CAPSULE, COATED, EXTENDED RELEASE",ORAL,20010411,,NDA,NDA020062,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,180,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0797,HUMAN PRESCRIPTION DRUG,Cardizem CD,,diltiazem hydrochloride,"CAPSULE, COATED, EXTENDED RELEASE",ORAL,20010411,,NDA,NDA020062,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,240,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0798,HUMAN PRESCRIPTION DRUG,Cardizem CD,,diltiazem hydrochloride,"CAPSULE, COATED, EXTENDED RELEASE",ORAL,20010411,,NDA,NDA020062,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,300,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0799,HUMAN PRESCRIPTION DRUG,Cardizem CD,,diltiazem hydrochloride,"CAPSULE, COATED, EXTENDED RELEASE",ORAL,20010411,,NDA,NDA020062,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,360,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0920,HUMAN PRESCRIPTION DRUG,Tetracaine Hydrochloride,,Tetracaine Hydrochloride,SOLUTION/ DROPS,OPHTHALMIC,20190627,,NDA,NDA210821,Bausch Health US LLC,TETRACAINE HYDROCHLORIDE,5,mg/mL,"Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]",,N,20251231,H10.9,"[{""icd10_code"":""H10.9"",""description"":""Unspecified conjunctivitis"",""confidence"":0.4,""context"":""eye infection""},{""icd10_code"":""H40.9"",""description"":""Unspecified glaucoma"",""confidence"":0.3,""context"":""glaucoma""},{""icd10_code"":""H16.9"",""description"":""Unspecified keratitis"",""confidence"":0.3,""context"":""corneal condition""}]",0.40
0187-0938,HUMAN PRESCRIPTION DRUG,Tasmar,,Tolcapone,"TABLET, FILM COATED",ORAL,20040727,,NDA,NDA020697,Bausch Health US LLC,TOLCAPONE,100,mg/1,"Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-0993,HUMAN PRESCRIPTION DRUG,Zovirax,,acyclovir,OINTMENT,TOPICAL,19820329,,NDA,NDA018604,"Bausch Health US, LLC",ACYCLOVIR,50,mg/g,"DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-0994,HUMAN PRESCRIPTION DRUG,Zovirax,,acyclovir,CREAM,TOPICAL,20021230,,NDA,NDA021478,"Bausch Health US, LLC",ACYCLOVIR,50,mg/g,"DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-1231,HUMAN PRESCRIPTION DRUG,Cesamet,,Nabilone,CAPSULE,ORAL,20200309,,NDA,NDA018677,Bausch Health US LLC,NABILONE,1,mg/1,"Cannabinoid [EPC], Cannabinoids [CS]",CII,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-1496,HUMAN PRESCRIPTION DRUG,Timoptic in Ocudose,,Timolol Maleate,SOLUTION,OPHTHALMIC,19861105,,NDA,NDA019463,Bausch Health US LLC,TIMOLOL MALEATE,6.8,mg/mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,H10.9,"[{""icd10_code"":""H10.9"",""description"":""Unspecified conjunctivitis"",""confidence"":0.4,""context"":""eye infection""},{""icd10_code"":""H40.9"",""description"":""Unspecified glaucoma"",""confidence"":0.3,""context"":""glaucoma""},{""icd10_code"":""H16.9"",""description"":""Unspecified keratitis"",""confidence"":0.3,""context"":""corneal condition""}]",0.40
0187-1498,HUMAN PRESCRIPTION DRUG,Timoptic in Ocudose,,Timolol Maleate,SOLUTION,OPHTHALMIC,19861105,,NDA,NDA019463,Bausch Health US LLC,TIMOLOL MALEATE,3.4,mg/mL,"Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",,N,20251231,H10.9,"[{""icd10_code"":""H10.9"",""description"":""Unspecified conjunctivitis"",""confidence"":0.4,""context"":""eye infection""},{""icd10_code"":""H40.9"",""description"":""Unspecified glaucoma"",""confidence"":0.3,""context"":""glaucoma""},{""icd10_code"":""H16.9"",""description"":""Unspecified keratitis"",""confidence"":0.3,""context"":""corneal condition""}]",0.40
0187-1660,HUMAN OTC DRUG,TheraSeal,,Dimethicone,CREAM,TOPICAL,20120101,,OTC MONOGRAPH DRUG,M014,"Bausch Health US, LLC",DIMETHICONE,1.7,g/170.1g,Skin Barrier Activity [PE],,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-2045,HUMAN PRESCRIPTION DRUG,Cardizem LA,,Diltiazem Hydrochloride,"TABLET, EXTENDED RELEASE",ORAL,20101225,,NDA,NDA021392,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,120,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-2046,HUMAN PRESCRIPTION DRUG,Cardizem LA,,Diltiazem Hydrochloride,"TABLET, EXTENDED RELEASE",ORAL,20101225,,NDA,NDA021392,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,180,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-2047,HUMAN PRESCRIPTION DRUG,Cardizem LA,,Diltiazem Hydrochloride,"TABLET, EXTENDED RELEASE",ORAL,20101225,,NDA,NDA021392,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,240,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-2048,HUMAN PRESCRIPTION DRUG,Cardizem LA,,Diltiazem Hydrochloride,"TABLET, EXTENDED RELEASE",ORAL,20101225,,NDA,NDA021392,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,300,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-2049,HUMAN PRESCRIPTION DRUG,Cardizem LA,,Diltiazem Hydrochloride,"TABLET, EXTENDED RELEASE",ORAL,20101225,,NDA,NDA021392,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,360,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-2050,HUMAN PRESCRIPTION DRUG,Cardizem LA,,Diltiazem Hydrochloride,"TABLET, EXTENDED RELEASE",ORAL,20101225,,NDA,NDA021392,Bausch Health US LLC,DILTIAZEM HYDROCHLORIDE,420,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-2098,HUMAN PRESCRIPTION DRUG,Arazlo,,tazarotene,LOTION,TOPICAL,20191219,,NDA,NDA211882,"Bausch Health US, LLC",TAZAROTENE,0.45,mg/g,"Retinoid [EPC], Retinoids [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-2120,HUMAN PRESCRIPTION DRUG,Syprine,,trientine hydrochloride,CAPSULE,ORAL,19851108,,NDA,NDA019194,Bausch Health US LLC,TRIENTINE HYDROCHLORIDE,250,mg/1,"Metal Chelating Activity [MoA], Metal Chelator [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-2612,HUMAN PRESCRIPTION DRUG,TIAZAC,EXTENDED RELEASE,diltiazem hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20140820,,NDA,NDA020401,"Bausch Health US, LLC",DILTIAZEM HYDROCHLORIDE,120,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-2613,HUMAN PRESCRIPTION DRUG,TIAZAC,EXTENDED RELEASE,diltiazem hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20140820,,NDA,NDA020401,"Bausch Health US, LLC",DILTIAZEM HYDROCHLORIDE,180,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-2614,HUMAN PRESCRIPTION DRUG,TIAZAC,EXTENDED RELEASE,diltiazem hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20140820,,NDA,NDA020401,"Bausch Health US, LLC",DILTIAZEM HYDROCHLORIDE,240,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-2615,HUMAN PRESCRIPTION DRUG,TIAZAC,EXTENDED RELEASE,diltiazem hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20140820,,NDA,NDA020401,"Bausch Health US, LLC",DILTIAZEM HYDROCHLORIDE,300,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-2616,HUMAN PRESCRIPTION DRUG,TIAZAC,EXTENDED RELEASE,diltiazem hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20140820,,NDA,NDA020401,"Bausch Health US, LLC",DILTIAZEM HYDROCHLORIDE,360,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-2617,HUMAN PRESCRIPTION DRUG,TIAZAC,EXTENDED RELEASE,diltiazem hydrochloride,"CAPSULE, EXTENDED RELEASE",ORAL,20140820,,NDA,NDA020401,"Bausch Health US, LLC",DILTIAZEM HYDROCHLORIDE,420,mg/1,"Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-3010,HUMAN PRESCRIPTION DRUG,Mestinon,,pyridostigmine bromide,TABLET,ORAL,19550406,,NDA,NDA009829,"Bausch Health US, LLC",PYRIDOSTIGMINE BROMIDE,60,mg/1,"Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-3012,HUMAN PRESCRIPTION DRUG,Mestinon,,pyridostigmine bromide,SOLUTION,ORAL,19650125,,NDA,NDA015193,"Bausch Health US, LLC",PYRIDOSTIGMINE BROMIDE,60,mg/5mL,"Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-3013,HUMAN PRESCRIPTION DRUG,Mestinon,,pyridostigmine bromide,"TABLET, EXTENDED RELEASE",ORAL,19590112,,NDA,NDA011665,"Bausch Health US, LLC",PYRIDOSTIGMINE BROMIDE,180,mg/1,"Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-3050,HUMAN PRESCRIPTION DRUG,ONEXTON,,Clindamycin Phosphate and Benzoyl Peroxide,GEL,TOPICAL,20141124,,NDA,NDA050819,"Bausch Health US, LLC",BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE,37.5; 10,mg/g; mg/g,"Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-3204,HUMAN PRESCRIPTION DRUG,Efudex,,Fluorouracil,CREAM,TOPICAL,19700729,,NDA,NDA016831,"Bausch Health US, LLC",FLUOROURACIL,2,g/40g,"Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]",,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-3554,HUMAN PRESCRIPTION DRUG,ANCOBON,,Flucytosine,CAPSULE,ORAL,19711126,,NDA,NDA017001,Bausch Health US LLC,FLUCYTOSINE,250,mg/1,"Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-3555,HUMAN PRESCRIPTION DRUG,ANCOBON,,Flucytosine,CAPSULE,ORAL,19711126,,NDA,NDA017001,Bausch Health US LLC,FLUCYTOSINE,500,mg/1,"Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-4100,HUMAN PRESCRIPTION DRUG,Librax,,Chlordiazepoxide Hydrochloride and Clidinium Bromide,CAPSULE,ORAL,19660901,,NDA,NDA012750,"Bausch Health US, LLC",CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE,5; 2.5,mg/1; mg/1,"Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-4420,HUMAN PRESCRIPTION DRUG,Pepcid,,famotidine,"TABLET, FILM COATED",ORAL,20010416,,ANDA,ANDA075805,Bausch Health US LLC,FAMOTIDINE,20,mg/1,"Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-4440,HUMAN PRESCRIPTION DRUG,Pepcid,,famotidine,"TABLET, FILM COATED",ORAL,20010416,,ANDA,ANDA075805,Bausch Health US LLC,FAMOTIDINE,40,mg/1,"Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-5100,HUMAN PRESCRIPTION DRUG,ELIDEL,,Pimecrolimus,CREAM,TOPICAL,20011202,,NDA,NDA021302,"Bausch Health US, LLC",PIMECROLIMUS,10,mg/g,"Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5101,HUMAN PRESCRIPTION DRUG,ELIDEL,,Pimecrolimus,CREAM,TOPICAL,20011202,,NDA,NDA021302,"Bausch Health US, LLC",PIMECROLIMUS,10,mg/g,"Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5102,HUMAN PRESCRIPTION DRUG,ELIDEL,,Pimecrolimus,CREAM,TOPICAL,20011202,,NDA,NDA021302,"Bausch Health US, LLC",PIMECROLIMUS,10,mg/g,"Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5103,HUMAN PRESCRIPTION DRUG,ELIDEL,,Pimecrolimus,CREAM,TOPICAL,20011202,,NDA,NDA021302,"Bausch Health US, LLC",PIMECROLIMUS,10,mg/g,"Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5104,HUMAN PRESCRIPTION DRUG,Xerese,,Acyclovir and Hydrocortisone,CREAM,TOPICAL,20090731,,NDA,NDA022436,Bausch Health US LLC,ACYCLOVIR; HYDROCORTISONE,50; 10,mg/g; mg/g,"Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5115,HUMAN PRESCRIPTION DRUG,Ertaczo,,Sertaconazole Nitrate,CREAM,TOPICAL,20031210,,NDA,NDA021385,"Bausch Health US, LLC",SERTACONAZOLE NITRATE,20,mg/g,"Azole Antifungal [EPC], Azoles [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5140,HUMAN PRESCRIPTION DRUG,Retin-A MICRO,,Tretinoin,GEL,TOPICAL,19970207,,NDA,NDA020475,Bausch Health US LLC,TRETINOIN,1,mg/g,"Retinoid [EPC], Retinoids [CS]",,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5144,HUMAN PRESCRIPTION DRUG,Retin-A MICRO,,Tretinoin,GEL,TOPICAL,20020510,,NDA,NDA020475,Bausch Health US LLC,TRETINOIN,0.4,mg/g,"Retinoid [EPC], Retinoids [CS]",,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5146,HUMAN PRESCRIPTION DRUG,Retin-A MICRO,,Tretinoin,GEL,TOPICAL,20171023,,NDA,NDA020475,Bausch Health US LLC,TRETINOIN,0.6,mg/g,"Retinoid [EPC], Retinoids [CS]",,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5148,HUMAN PRESCRIPTION DRUG,Retin-A MICRO,,Tretinoin,GEL,TOPICAL,20140128,,NDA,NDA020475,Bausch Health US LLC,TRETINOIN,0.8,mg/g,"Retinoid [EPC], Retinoids [CS]",,N,20261231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5150,HUMAN PRESCRIPTION DRUG,Renova,,Tretinoin,CREAM,TOPICAL,20000831,,NDA,NDA021108,Bausch Health US LLC,TRETINOIN,0.2,mg/g,"Retinoid [EPC], Retinoids [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5160,HUMAN PRESCRIPTION DRUG,Retin-A,,Tretinoin,CREAM,TOPICAL,19881030,,NDA,NDA019049,"Bausch Health US, LLC",TRETINOIN,0.25,mg/g,"Retinoid [EPC], Retinoids [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5162,HUMAN PRESCRIPTION DRUG,Retin-A,,Tretinoin,CREAM,TOPICAL,19740730,,NDA,NDA017522,"Bausch Health US, LLC",TRETINOIN,0.5,mg/g,"Retinoid [EPC], Retinoids [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5164,HUMAN PRESCRIPTION DRUG,Retin-A,,Tretinoin,CREAM,TOPICAL,19730430,,NDA,NDA017340,"Bausch Health US, LLC",TRETINOIN,1,mg/g,"Retinoid [EPC], Retinoids [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5170,HUMAN PRESCRIPTION DRUG,Retin-A,,Tretinoin,GEL,TOPICAL,19750730,,NDA,NDA017579,"Bausch Health US, LLC",TRETINOIN,0.25,mg/g,"Retinoid [EPC], Retinoids [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5172,HUMAN PRESCRIPTION DRUG,Retin-A,,Tretinoin,GEL,TOPICAL,19790730,,NDA,NDA017955,"Bausch Health US, LLC",TRETINOIN,0.1,mg/g,"Retinoid [EPC], Retinoids [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5190,HUMAN PRESCRIPTION DRUG,Benzaclin,,Clindamycin phosphate and benzoyl peroxide,GEL,TOPICAL,20001221,,NDA,NDA050756,Bausch Health US LLC,BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE,50; 10,mg/g; mg/g,"Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5198,HUMAN PRESCRIPTION DRUG,Klaron,,sulfacetamide sodium,LOTION,TOPICAL,19961223,,NDA,NDA019931,"Bausch Health US, LLC",SULFACETAMIDE SODIUM,100,mg/mL,"Sulfonamide Antibacterial [EPC], Sulfonamides [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5202,HUMAN PRESCRIPTION DRUG,Noritate,,metronidazole,CREAM,TOPICAL,20130809,,NDA,NDA020743,"Bausch Health US, LLC",METRONIDAZOLE,10,mg/60g,"Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5205,HUMAN PRESCRIPTION DRUG,Benzamycin,,erythromycin and benzoyl peroxide,KIT,,19841026,,NDA,NDA050557,"Bausch Health US, LLC",,,,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-5400,HUMAN PRESCRIPTION DRUG,JUBLIA,,efinaconazole,SOLUTION,TOPICAL,20140606,,NDA,NDA203567,Bausch Health US LLC,EFINACONAZOLE,100,mg/mL,"Azole Antifungal [EPC], Azoles [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5465,HUMAN OTC DRUG,Caladryl,,"Ferric Oxide Red, Zinc Oxide, and Pramoxine Hydrochloride",LOTION,TOPICAL,20130816,,OTC MONOGRAPH DRUG,M014,"Bausch Health US, LLC",FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE,1.36; 10; 78.65,mg/mL; mg/mL; mg/mL,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5466,HUMAN OTC DRUG,Caladryl Clear,,PRAMOXINE HYDROCHLORIDE and ZINC ACETATE,LOTION,TOPICAL,20130816,,OTC MONOGRAPH DRUG,M014,"Bausch Health US, LLC",PRAMOXINE HYDROCHLORIDE; ZINC ACETATE,10; 1,mg/mL; mg/mL,"Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5525,HUMAN PRESCRIPTION DRUG,Targretin,,bexarotene,GEL,TOPICAL,20000628,,NDA,NDA021056,"Bausch Health US, LLC",BEXAROTENE,1,g/100g,"Retinoid [EPC], Retinoids [CS]",,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0187-5526,HUMAN PRESCRIPTION DRUG,Targretin,,bexarotene,"CAPSULE, LIQUID FILLED",ORAL,19991229,,NDA,NDA021055,"Bausch Health US, LLC",BEXAROTENE,75,mg/1,"Retinoid [EPC], Retinoids [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-5600,HUMAN PRESCRIPTION DRUG,Visudyne,,verteporfin for injection,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20000412,,NDA,NDA021119,Bausch Health US LLC,VERTEPORFIN,15,mg/1,"Photoabsorption [MoA], Photoenhancer [EPC], Photosensitizing Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-5810,HUMAN PRESCRIPTION DRUG,Aplenzin,,bupropion hydrobromide,"TABLET, EXTENDED RELEASE",ORAL,20080423,,NDA,NDA022108,"Bausch Health US, LLC",BUPROPION HYDROBROMIDE,174,mg/1,"Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-5811,HUMAN PRESCRIPTION DRUG,Aplenzin,,bupropion hydrobromide,"TABLET, EXTENDED RELEASE",ORAL,20080423,,NDA,NDA022108,"Bausch Health US, LLC",BUPROPION HYDROBROMIDE,348,mg/1,"Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0187-5812,HUMAN PRESCRIPTION DRUG,Aplenzin,,bupropion hydrobromide,"TABLET, EXTENDED RELEASE",ORAL,20080423,,NDA,NDA022108,"Bausch Health US, LLC",BUPROPION HYDROBROMIDE,522,mg/1,"Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0206-8860,HUMAN PRESCRIPTION DRUG,Zosyn,in Galaxy Containers,TAZOBACTAM SODIUM and PIPERACILLIN SODIUM,"INJECTION, SOLUTION",INTRAVENOUS,19980301,,NDA,NDA050750,"Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",PIPERACILLIN SODIUM; TAZOBACTAM SODIUM,2; 250,g/50mL; mg/50mL,"Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0206-8861,HUMAN PRESCRIPTION DRUG,Zosyn,in Galaxy Containers,TAZOBACTAM SODIUM and PIPERACILLIN SODIUM,"INJECTION, SOLUTION",INTRAVENOUS,19980301,,NDA,NDA050750,"Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",PIPERACILLIN SODIUM; TAZOBACTAM SODIUM,3; 375,g/50mL; mg/50mL,"Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0206-8862,HUMAN PRESCRIPTION DRUG,Zosyn,in Galaxy Containers,TAZOBACTAM SODIUM and PIPERACILLIN SODIUM,"INJECTION, SOLUTION",INTRAVENOUS,19980301,,NDA,NDA050750,"Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",PIPERACILLIN SODIUM; TAZOBACTAM SODIUM,4; 500,g/100mL; mg/100mL,"Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0219-0203,HUMAN OTC DRUG,Humphreys Bendito Alcoholado,,menthol,LIQUID,TOPICAL,19720111,,OTC MONOGRAPH DRUG,M017,"Humphreys Pharmacal, Incorporated","MENTHOL, UNSPECIFIED FORM",12.5,mg/mL,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0219-0204,HUMAN OTC DRUG,Humphreys Maravilla,,witch hazel,LIQUID,TOPICAL,19550111,,OTC MONOGRAPH DRUG,M016,"Humphreys Pharmacal, Incorporated",WITCH HAZEL,1,g/mL,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0220-0002,HUMAN OTC DRUG,ABELMOSCHUS,,ABELMOSCHUS MOSCHATUS SEED,PELLET,ORAL,20171019,,UNAPPROVED HOMEOPATHIC,,BOIRON,ABELMOSCHUS MOSCHATUS SEED,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0003,HUMAN OTC DRUG,ABELMOSCHUS,,ABELMOSCHUS MOSCHATUS SEED,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ABELMOSCHUS MOSCHATUS SEED,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0006,HUMAN OTC DRUG,Abies canadensis,,TSUGA CANADENSIS BARK TSUGA CANADENSIS FLOWER BUD,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TSUGA CANADENSIS BARK; TSUGA CANADENSIS FLOWER BUD,9; 9,[hp_C]/9[hp_C]; [hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0008,HUMAN OTC DRUG,Abies nigra,,PICEA MARIANA RESIN,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,PICEA MARIANA RESIN,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0010,HUMAN OTC DRUG,Abies Nigra,,PICEA MARIANA RESIN,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,PICEA MARIANA RESIN,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0011,HUMAN OTC DRUG,Abies Nigra,,PICEA MARIANA RESIN,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,PICEA MARIANA RESIN,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0014,HUMAN OTC DRUG,Abrotanum,,ARTEMISIA ABROTANUM FLOWERING TOP,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARTEMISIA ABROTANUM FLOWERING TOP,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0015,HUMAN OTC DRUG,Abrotanum,,ARTEMISIA ABROTANUM FLOWERING TOP,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ARTEMISIA ABROTANUM FLOWERING TOP,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0018,HUMAN PRESCRIPTION DRUG,Absinthium,,WORMWOOD,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,WORMWOOD,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0027,HUMAN OTC DRUG,Aconitum napellus,,ACONITUM NAPELLUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACONITUM NAPELLUS,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0028,HUMAN OTC DRUG,Aconitum napellus,,ACONITUM NAPELLUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACONITUM NAPELLUS,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0030,HUMAN PRESCRIPTION DRUG,Aceticum acidum,,ACETIC ACID,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACETIC ACID,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0031,HUMAN OTC DRUG,Aconitum napellus,,ACONITUM NAPELLUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACONITUM NAPELLUS,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0032,HUMAN OTC DRUG,Aconitum napellus,,ACONITUM NAPELLUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACONITUM NAPELLUS,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0035,HUMAN OTC DRUG,Aconitum napellus,,ACONITUM NAPELLUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACONITUM NAPELLUS,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0036,HUMAN OTC DRUG,Aconitum napellus,,ACONITUM NAPELLUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACONITUM NAPELLUS,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0039,HUMAN OTC DRUG,Aconitum napellus,,ACONITUM NAPELLUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACONITUM NAPELLUS,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0040,HUMAN OTC DRUG,Aconitum napellus,,ACONITUM NAPELLUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACONITUM NAPELLUS,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0043,HUMAN OTC DRUG,Aconitum napellus,,ACONITUM NAPELLUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACONITUM NAPELLUS,12,[hp_X]/12[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0045,HUMAN OTC DRUG,Aconitum napellus,,ACONITUM NAPELLUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACONITUM NAPELLUS,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0052,HUMAN OTC DRUG,Aconitum napellus,,ACONITUM NAPELLUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACONITUM NAPELLUS,6,[hp_X]/6[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0053,HUMAN OTC DRUG,Actaea spicata,,ACTAEA SPICATA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTAEA SPICATA ROOT,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0054,HUMAN OTC DRUG,Actaea spicata,,ACTAEA SPICATA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTAEA SPICATA ROOT,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0055,HUMAN OTC DRUG,Actaea spicata,,ACTAEA SPICATA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTAEA SPICATA ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0056,HUMAN OTC DRUG,Actaea spicata,,ACTAEA SPICATA ROOT,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTAEA SPICATA ROOT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0060,HUMAN OTC DRUG,Actaea Spicata,,ACTAEA SPICATA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTAEA SPICATA ROOT,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0076,HUMAN OTC DRUG,Adrenalinum,,EPINEPHRINE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,EPINEPHRINE,30,[hp_C]/30[hp_C],"Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0078,HUMAN PRESCRIPTION DRUG,Adrenalinum,,EPINEPHRINE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,EPINEPHRINE,200,[kp_C]/200[kp_C],"Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0081,HUMAN OTC DRUG,Aesculus hippocastanum,,HORSE CHESTNUT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,HORSE CHESTNUT,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0082,HUMAN OTC DRUG,Aesculus hippocastanum,,HORSE CHESTNUT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,HORSE CHESTNUT,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0085,HUMAN OTC DRUG,Aesculus hippocastanum,,HORSE CHESTNUT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,HORSE CHESTNUT,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0086,HUMAN OTC DRUG,Aesculus hippocastanum,,HORSE CHESTNUT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,HORSE CHESTNUT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0089,HUMAN OTC DRUG,Aesculus hippocastanum,,HORSE CHESTNUT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,HORSE CHESTNUT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0092,HUMAN OTC DRUG,Aesculus hippocastanum,,HORSE CHESTNUT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,HORSE CHESTNUT,6,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0098,HUMAN OTC DRUG,Aesculus hippocastanum,,HORSE CHESTNUT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,HORSE CHESTNUT,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0104,HUMAN OTC DRUG,Aethusa cynapium,,AETHUSA CYNAPIUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AETHUSA CYNAPIUM,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0105,HUMAN OTC DRUG,Aethusa cynapium,,AETHUSA CYNAPIUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AETHUSA CYNAPIUM,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0109,HUMAN OTC DRUG,Aethusa cynapium,,AETHUSA CYNAPIUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AETHUSA CYNAPIUM,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0110,HUMAN OTC DRUG,Agaricus muscarius,,AMANITA MUSCARIA FRUITING BODY,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMANITA MUSCARIA FRUITING BODY,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0113,HUMAN OTC DRUG,Agaricus muscarius,,AMANITA MUSCARIA FRUITING BODY,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMANITA MUSCARIA FRUITING BODY,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0114,HUMAN OTC DRUG,Agaricus muscarius,,AMANITA MUSCARIA FRUITING BODY,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMANITA MUSCARIA FRUITING BODY,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0117,HUMAN OTC DRUG,Agaricus muscarius,,AMANITA MUSCARIA FRUITING BODY,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMANITA MUSCARIA FRUITING BODY,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0118,HUMAN OTC DRUG,Agaricus muscarius,,AMANITA MUSCARIA FRUITING BODY,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMANITA MUSCARIA FRUITING BODY,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0121,HUMAN OTC DRUG,Agaricus muscarius,,AMANITA MUSCARIA FRUITING BODY,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMANITA MUSCARIA FRUITING BODY,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0122,HUMAN OTC DRUG,Agaricus muscarius,,AMANITA MUSCARIA FRUITING BODY,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMANITA MUSCARIA FRUITING BODY,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0124,HUMAN OTC DRUG,Agaricus muscarius,,AMANITA MUSCARIA WHOLE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMANITA MUSCARIA WHOLE,6,[hp_X]/6[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0125,HUMAN PRESCRIPTION DRUG,Agnus castus,,CHASTE TREE FRUIT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CHASTE TREE FRUIT,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0126,HUMAN PRESCRIPTION DRUG,Agnus castus,,CHASTE TREE FRUIT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CHASTE TREE FRUIT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0129,HUMAN PRESCRIPTION DRUG,Agnus castus,,CHASTE TREE FRUIT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CHASTE TREE FRUIT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0130,HUMAN PRESCRIPTION DRUG,Agnus castus,,CHASTE TREE FRUIT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CHASTE TREE FRUIT,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0140,HUMAN PRESCRIPTION DRUG,Agnus castus,,CHASTE TREE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CHASTE TREE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0141,HUMAN OTC DRUG,Agraphis nutans,,HYACINTHOIDES NON-SCRIPTA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,HYACINTHOIDES NON-SCRIPTA,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0142,HUMAN OTC DRUG,Agraphis nutans,,HYACINTHOIDES NON-SCRIPTA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,HYACINTHOIDES NON-SCRIPTA,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0144,HUMAN OTC DRUG,Agraphis nutans,,HYACINTHOIDES NON SCRIPTA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,HYACINTHOIDES NON-SCRIPTA,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0145,HUMAN OTC DRUG,Agraphis Nutans,,HYACINTHOIDES NON-SCRIPTA WHOLE,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,HYACINTHOIDES NON-SCRIPTA,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0153,HUMAN OTC DRUG,Aletris Farinosa,,ALETRIS FARINOSA ROOT,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ALETRIS FARINOSA ROOT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0156,HUMAN OTC DRUG,AILANTHUS GLANDULOSUS,,AILANTHUS ALTISSIMA FLOWERING TWIG,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AILANTHUS ALTISSIMA FLOWERING TWIG,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0157,HUMAN OTC DRUG,Allium cepa,,ONION,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ONION,5,[hp_C]/5[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0158,HUMAN OTC DRUG,Allium cepa,,ONION,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ONION,6,[hp_C]/6[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0160,HUMAN OTC DRUG,Aletris farinosa,,ALETRIS FARINOSA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALETRIS FARINOSA ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0161,HUMAN OTC DRUG,Alfalfa,,ALFALFA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALFALFA,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0164,HUMAN OTC DRUG,Alfalfa,,ALFALFA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALFALFA,6,[hp_X]/6[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0165,HUMAN OTC DRUG,Allium cepa,,ONION,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ONION,9,[hp_C]/9[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0166,HUMAN OTC DRUG,Allium cepa,,ONION,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ONION,12,[hp_C]/12[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0169,HUMAN OTC DRUG,Allium cepa,,ONION,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ONION,15,[hp_C]/15[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0170,HUMAN OTC DRUG,Allium cepa,,ONION,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ONION,30,[hp_C]/30[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0172,HUMAN OTC DRUG,Allium cepa,,ONION,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ONION,6,[hp_X]/1,"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0174,HUMAN OTC DRUG,Allium cepa,,ONION,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ONION,30,[hp_X]/30[hp_X],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0177,HUMAN OTC DRUG,Allium sativum,,GARLIC,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GARLIC,30,[hp_C]/30[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0178,HUMAN OTC DRUG,Allium cepa,,ONION,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ONION,200,[kp_C]/200[kp_C],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0179,HUMAN OTC DRUG,Allium cepa,,ONION,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ONION,1,[hp_M]/[hp_M],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0182,HUMAN OTC DRUG,Alumina,,ALUMINUM OXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALUMINUM OXIDE,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0183,HUMAN OTC DRUG,Alumina,,ALUMINUM OXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALUMINUM OXIDE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0186,HUMAN OTC DRUG,Allium sativum,,GARLIC,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,GARLIC,200,[kp_C]/200[kp_C],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0187,HUMAN OTC DRUG,Aloe,,ALOE FEROX LEAF,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALOE FEROX LEAF,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0189,HUMAN OTC DRUG,Aloe,,ALOE FEROX LEAF,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALOE FEROX LEAF,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0190,HUMAN OTC DRUG,Aloe,,ALOE FEROX LEAF,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALOE FEROX LEAF,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0191,HUMAN OTC DRUG,Aloe,,ALOE FEROX LEAF,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALOE FEROX LEAF,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0194,HUMAN OTC DRUG,Alumina,,ALUMINUM OXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALUMINUM OXIDE,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0195,HUMAN OTC DRUG,Alumina,,ALUMINUM OXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALUMINUM OXIDE,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0198,HUMAN OTC DRUG,Alumina,,ALUMINUM OXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALUMINUM OXIDE,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0199,HUMAN OTC DRUG,Alumina,,ALUMINUM OXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALUMINUM OXIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0201,HUMAN OTC DRUG,Alumen,,POTASSIUM ALUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,POTASSIUM ALUM,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0205,HUMAN OTC DRUG,Alumina,,ALUMINUM OXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALUMINUM OXIDE,30,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0209,HUMAN OTC DRUG,Alumina silicata,,KAOLIN,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,KAOLIN,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0211,HUMAN OTC DRUG,Alumina,,ALUMINUM OXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALUMINUM OXIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0213,HUMAN OTC DRUG,Aluminum metallicum,,ALUMINUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALUMINUM,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0215,HUMAN OTC DRUG,Alumina,,ALUMINUM OXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ALUMINUM OXIDE,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0218,HUMAN OTC DRUG,Ambrosia artemisiaefolia,,AMBROSIA ARTEMISIIFOLIA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMBROSIA ARTEMISIIFOLIA,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0219,HUMAN OTC DRUG,Ambrosia artemisiaefolia,,AMBROSIA ARTEMISIIFOLIA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMBROSIA ARTEMISIIFOLIA,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0222,HUMAN OTC DRUG,Aloe,,ALOE FEROX LEAF,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ALOE FEROX LEAF,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0223,HUMAN OTC DRUG,Alumen,,POTASSIUM ALUM,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,POTASSIUM ALUM,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0226,HUMAN OTC DRUG,Alumina silicata,,KAOLIN,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,KAOLIN,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0229,HUMAN OTC DRUG,Aluminum metallicum,,ALUMINUM,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ALUMINUM,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0230,HUMAN OTC DRUG,AMBROSIA ARTEMISIAEFOLIA,,AMBROSIA ARTEMISIIFOLIA,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,AMBROSIA ARTEMISIIFOLIA,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0241,HUMAN OTC DRUG,Ammonium carbonicum,,AMMONIUM CARBONATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMMONIUM CARBONATE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0242,HUMAN OTC DRUG,Ammonium carbonicum,,AMMONIUM CARBONATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMMONIUM CARBONATE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0248,HUMAN OTC DRUG,Ammonium carbonicum,,AMMONIUM CARBONATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMMONIUM CARBONATE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0249,HUMAN OTC DRUG,Ammonium muriaticum,,AMMONIUM CHLORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMMONIUM CHLORIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0250,HUMAN OTC DRUG,Ammonium muriaticum,,AMMONIUM CHLORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMMONIUM CHLORIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0260,HUMAN OTC DRUG,Ammonium muriaticum,,AMMONIUM CHLORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMMONIUM CHLORIDE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0268,HUMAN OTC DRUG,Ammonium phosphoricum,,AMMONIUM PHOSPHATE DIBASIC,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,"AMMONIUM PHOSPHATE, DIBASIC",30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0269,HUMAN OTC DRUG,Ammonium phosphoricum,,AMMONIUM PHOSPHATE DIBASIC,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,"AMMONIUM PHOSPHATE, DIBASIC",200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0285,HUMAN OTC DRUG,Anacardium orientale,,SEMECARPUS ANACARDIUM JUICE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SEMECARPUS ANACARDIUM JUICE,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0286,HUMAN OTC DRUG,Anacardium orientale,,SEMECARPUS ANACARDIUM JUICE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SEMECARPUS ANACARDIUM JUICE,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0289,HUMAN OTC DRUG,Anacardium orientale,,SEMECARPUS ANACARDIUM JUICE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SEMECARPUS ANACARDIUM JUICE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0290,HUMAN OTC DRUG,Anacardium orientale,,SEMECARPUS ANACARDIUM JUICE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SEMECARPUS ANACARDIUM JUICE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0296,HUMAN PRESCRIPTION DRUG,Amygdalus persica,,PRUNUS PERSICA FLOWER,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,PRUNUS PERSICA FLOWER,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0297,HUMAN OTC DRUG,Anacardium orientale,,SEMECARPUS ANACARDIUM JUICE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SEMECARPUS ANACARDIUM JUICE,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0298,HUMAN OTC DRUG,Anacardium orientale,,SEMECARPUS ANACARDIUM JUICE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SEMECARPUS ANACARDIUM JUICE,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0300,HUMAN OTC DRUG,Amyl nitrosum,,AMYL NITRITE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMYL NITRITE,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0301,HUMAN OTC DRUG,Amyl nitrosum,,AMYL NITRITE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AMYL NITRITE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0302,HUMAN OTC DRUG,Amyl nitrosum,,AMYL NITRITE,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,AMYL NITRITE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0304,HUMAN OTC DRUG,Anacardium occidentale,,ANACARDIUM OCCIDENTALE FRUIT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANACARDIUM OCCIDENTALE FRUIT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0308,HUMAN OTC DRUG,Anacardium orientale,,SEMECARPUS ANACARDIUM JUICE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SEMECARPUS ANACARDIUM JUICE,6,[hp_C]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0312,HUMAN OTC DRUG,Anagallis arvensis,,ANAGALLIS ARVENSIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANAGALLIS ARVENSIS,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0313,HUMAN OTC DRUG,Anagallis Arvensis,,Anagallis Arvensis,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ANAGALLIS ARVENSIS,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0320,HUMAN OTC DRUG,Anatherum muriaticum,,CHRYSOPOGON ZIZANIOIDES ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CHRYSOPOGON ZIZANIOIDES ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0321,HUMAN OTC DRUG,Anatherum muricatum,,CHRYSOPOGON ZIZANIOIDES ROOT,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,CHRYSOPOGON ZIZANIOIDES ROOT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0345,HUMAN OTC DRUG,Antimonium crudum,,ANTIMONY TRISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY TRISULFIDE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0346,HUMAN OTC DRUG,Antimonium crudum,,ANTIMONY TRISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY TRISULFIDE,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0349,HUMAN OTC DRUG,Antimonium crudum,,ANTIMONY TRISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY TRISULFIDE,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0350,HUMAN OTC DRUG,Antimonium crudum,,ANTIMONY TRISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY TRISULFIDE,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0353,HUMAN OTC DRUG,Antimonium crudum,,ANTIMONY TRISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY TRISULFIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0354,HUMAN OTC DRUG,Antimonium crudum,,ANTIMONY TRISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY TRISULFIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0357,HUMAN OTC DRUG,Antimonium crudum,,ANTIMONY TRISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY TRISULFIDE,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0358,HUMAN OTC DRUG,Antimonium crudum,,ANTIMONY TRISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY TRISULFIDE,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0365,HUMAN OTC DRUG,Antimonium tartaricum,,ANTIMONY POTASSIUM TARTRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY POTASSIUM TARTRATE,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0366,HUMAN OTC DRUG,Antimonium tartaricum,,ANTIMONY POTASSIUM TARTRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY POTASSIUM TARTRATE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0369,HUMAN OTC DRUG,Antimonium crudum,,ANTIMONY TRISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY TRISULFIDE,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0372,HUMAN OTC DRUG,Antimonium crudum,,ANTIMONY TRISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY TRISULFIDE,8,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0375,HUMAN OTC DRUG,Antimonium tartaricum,,ANTIMONY POTASSIUM TARTRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY POTASSIUM TARTRATE,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0377,HUMAN OTC DRUG,Antimonium iodatum,,ANTIMONY TRIIODIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY TRIIODIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0378,HUMAN OTC DRUG,Antimonium tartaricum,,ANTIMONY POTASSIUM TARTRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY POTASSIUM TARTRATE,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0379,HUMAN OTC DRUG,Antimonium tartaricum,,ANTIMONY POTASSIUM TARTRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY POTASSIUM TARTRATE,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0382,HUMAN OTC DRUG,Antimonium tartaricum,,ANTIMONY POTASSIUM TARTRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY POTASSIUM TARTRATE,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0383,HUMAN OTC DRUG,Antimonium tartaricum,,ANTIMONY POTASSIUM TARTRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY POTASSIUM TARTRATE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0386,HUMAN OTC DRUG,Antimonium tartaricum,,ANTIMONY POTASSIUM TARTRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY POTASSIUM TARTRATE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0387,HUMAN OTC DRUG,Antimonium tartaricum,,ANTIMONY POTASSIUM TARTRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY POTASSIUM TARTRATE,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0393,HUMAN OTC DRUG,Antimonium tartaricum,,ANTIMONY POTASSIUM TARTRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY POTASSIUM TARTRATE,6,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0399,HUMAN OTC DRUG,Apis mellifica,,APIS MELLIFERA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA,5,[hp_C]/5[hp_C],"Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0400,HUMAN OTC DRUG,Apis mellifica,,APIS MELLIFERA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA,6,[hp_C]/6[hp_C],"Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0403,HUMAN OTC DRUG,Apis mellifica,,APIS MELLIFERA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA,9,[hp_C]/9[hp_C],"Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0404,HUMAN OTC DRUG,Apis mellifica,,APIS MELLIFERA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA,12,[hp_C]/12[hp_C],"Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0406,HUMAN OTC DRUG,Apis mellifica,,APIS MELLIFERA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA,6,[hp_X]/1,"Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0408,HUMAN OTC DRUG,Apis mellifica,,APIS MELLIFERA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA,15,[hp_C]/15[hp_C],"Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0409,HUMAN OTC DRUG,Apis mellifica,,APIS MELLIFERA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA,30,[hp_C]/30[hp_C],"Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0410,HUMAN OTC DRUG,Apis mellifica,,APIS MELLIFERA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA,200,[kp_C]/200[kp_C],"Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0411,HUMAN OTC DRUG,Apis mellifica,,APIS MELLIFERA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA,1,[hp_M]/[hp_M],"Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0412,HUMAN OTC DRUG,Apis mellifica,,APIS MELLIFERA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA,10,[hp_M]/10[hp_M],"Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0413,HUMAN OTC DRUG,Apis mellifica,,APIS MELLIFERA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA,12,[hp_X]/12[hp_X],"Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]",,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0416,HUMAN OTC DRUG,Apis venenum purum,,APIS MELLIFERA VENOM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA VENOM,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0417,HUMAN OTC DRUG,Apis mellifica,,APIS MELLIFERA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA,30,[hp_X]/30[hp_X],"Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0418,HUMAN OTC DRUG,Antimonium iodatum,,ANTIMONY TRIIODIDE,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ANTIMONY TRIIODIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0421,HUMAN OTC DRUG,Apocynum cannabinum,,APOCYNUM CANNABINUM ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APOCYNUM CANNABINUM ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0425,HUMAN OTC DRUG,Apis venenum purum,,APIS MELLIFERA VENOM,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,APIS MELLIFERA VENOM,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0428,HUMAN PRESCRIPTION DRUG,Apocynum cannabinum,,APOCYNUM CANNABINUM ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,APOCYNUM CANNABINUM ROOT,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0432,HUMAN OTC DRUG,Aqua marina,,SODIUM CHLORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM CHLORIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0433,HUMAN OTC DRUG,Aqua marina,,SODIUM CHLORIDE,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM CHLORIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0438,HUMAN OTC DRUG,Aralia racemosa,,ARALIA RACEMOSA ROOT,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ARALIA RACEMOSA ROOT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0441,HUMAN OTC DRUG,Aranea diadema,,ARANEUS DIADEMATUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARANEUS DIADEMATUS,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0442,HUMAN OTC DRUG,Aralia racemosa,,ARALIA RACEMOSA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARALIA RACEMOSA ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0444,HUMAN OTC DRUG,Aralia racemosa,,ARALIA RACEMOSA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARALIA RACEMOSA ROOT,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0448,HUMAN OTC DRUG,Aranea diadema,,ARANEUS DIADEMATUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARANEUS DIADEMATUS,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0449,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,12,[hp_X]/12[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0450,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0453,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,200,[hp_X]/200[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0454,HUMAN OTC DRUG,Aranea diadema,,ARANEUS DIADEMATUS,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ARANEUS DIADEMATUS,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0457,HUMAN OTC DRUG,Argentum nitricum,,SILVER NITRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER NITRATE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0458,HUMAN OTC DRUG,Argentum nitricum,,SILVER NITRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER NITRATE,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0461,HUMAN OTC DRUG,Argentum nitricum,,SILVER NITRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER NITRATE,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0462,HUMAN OTC DRUG,Argentum nitricum,,SILVER NITRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER NITRATE,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0465,HUMAN OTC DRUG,Argentum nitricum,,SILVER NITRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER NITRATE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0466,HUMAN OTC DRUG,Argentum nitricum,,SILVER NITRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER NITRATE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0469,HUMAN OTC DRUG,Argentum nitricum,,SILVER NITRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER NITRATE,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0470,HUMAN OTC DRUG,Argentum nitricum,,SILVER NITRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER NITRATE,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0473,HUMAN OTC DRUG,Argentum nitricum,,SILVER NITRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER NITRATE,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0476,HUMAN OTC DRUG,Argentum metallicum,,SILVER,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0477,HUMAN OTC DRUG,Argentum metallicum,,SILVER,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0478,HUMAN OTC DRUG,Argentum metallicum,,SILVER,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0481,HUMAN OTC DRUG,Argentum nitricum,,SILVER NITRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER NITRATE,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0484,HUMAN OTC DRUG,Argentum nitricum,,SILVER NITRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SILVER NITRATE,6,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0486,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,3,[hp_C]/3[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0489,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0490,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0493,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,8,[hp_C]/8[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0496,HUMAN OTC DRUG,Aristolochia clematitis,,ARISTOLOCHIA CLEMATITIS ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARISTOLOCHIA CLEMATITIS ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0497,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0498,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0501,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0502,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0505,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0508,HUMAN OTC DRUG,Arnica,,ARNICA MONTANA,PELLET,ORAL,20090501,,UNAPPROVED HOMEOPATHIC,,Laboratoires Boiron,ARNICA MONTANA,30,[hp_C]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0514,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0515,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,3,[hp_X]/3[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0518,HUMAN OTC DRUG,Arnica montana radix,,ARNICA MONTANA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0519,HUMAN OTC DRUG,Arnica montana,,ARNICA MONTANA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA,6,[hp_X]/6[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0522,HUMAN OTC DRUG,Arsenicum album,,ARSENIC TRIOXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIOXIDE,6,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0525,HUMAN OTC DRUG,Arsenicum album,,ARSENIC TRIOXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIOXIDE,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0526,HUMAN OTC DRUG,Arsenicum album,,ARSENIC TRIOXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIOXIDE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0527,HUMAN OTC DRUG,Arsenicum album,,ARSENIC TRIOXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIOXIDE,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0528,HUMAN OTC DRUG,Arsenicum album,,ARSENIC TRIOXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIOXIDE,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0529,HUMAN OTC DRUG,Arsenicum album,,ARSENIC TRIOXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIOXIDE,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0530,HUMAN OTC DRUG,Arsenicum album,,ARSENIC TRIOXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIOXIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0532,HUMAN OTC DRUG,Arsenicum bromatum,,ARSENIC TRIBROMIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIBROMIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0536,HUMAN OTC DRUG,Arsenicum iodatum,,ARSENIC TRIIODIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIIODIDE,6,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0538,HUMAN OTC DRUG,Aristolochia clematitis,,ARISTOLOCHIA CLEMATITIS ROOT,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ARISTOLOCHIA CLEMATITIS ROOT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0540,HUMAN OTC DRUG,Arsenicum metallicum,,ARSENIC,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0541,HUMAN OTC DRUG,Arnica montana radix,,ARNICA MONTANA ROOT,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ARNICA MONTANA ROOT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0544,HUMAN OTC DRUG,Arsenicum sulphuratum flavum,,ARSENIC TRISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRISULFIDE,8,[hp_X]/8[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0545,HUMAN OTC DRUG,Arsenicum sulphuratum flavum,,ARSENIC TRISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRISULFIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0548,HUMAN OTC DRUG,Arsenicum sulphuratum rubrum,,TETRAARSENIC TETRASULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TETRAARSENIC TETRASULFIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0549,HUMAN OTC DRUG,Arsenicum album,,ARSENIC TRIOXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIOXIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0550,HUMAN OTC DRUG,Arsenicum album,,ARSENIC TRIOXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIOXIDE,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0552,HUMAN OTC DRUG,Artemisia vulgaris,,ARTEMISIA VULGARIS ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARTEMISIA VULGARIS ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0553,HUMAN OTC DRUG,Arsenicum album,,ARSENIC TRIOXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIOXIDE,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0554,HUMAN OTC DRUG,Arsenicum album,,ARSENIC TRIOXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIOXIDE,12,[hp_X]/12[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0557,HUMAN OTC DRUG,Arsenicum album,,ARSENIC TRIOXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIOXIDE,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0560,HUMAN OTC DRUG,Arum maculatum,,ARUM MACULATUM ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARUM MACULATUM ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0561,HUMAN OTC DRUG,Arsenicum iodatum,,ARSENIC TRIIODIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIIODIDE,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0562,HUMAN OTC DRUG,Arsenicum iodatum,,ARSENIC TRIIODIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIIODIDE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0564,HUMAN OTC DRUG,Arum triphyllum,,ARISAEMA TRIPHYLLUM ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARISAEMA TRIPHYLLUM ROOT,6,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0565,HUMAN OTC DRUG,Arum triphyllum,,ARISAEMA TRIPHYLLUM ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARISAEMA TRIPHYLLUM ROOT,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0566,HUMAN OTC DRUG,Arsenicum bromatum,,ARSENIC TRIBROMIDE,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIBROMIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0568,HUMAN OTC DRUG,Arundo mauritanica,,ARUNDO PLINIANA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARUNDO PLINIANA ROOT,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0569,HUMAN OTC DRUG,Arundo mauritanica,,ARUNDO PLINIANA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARUNDO PLINIANA ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0572,HUMAN OTC DRUG,Asafoetida,,FERULA ASSA-FOETIDA RESIN,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,FERULA ASSA-FOETIDA RESIN,3,[hp_X]/3[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0573,HUMAN OTC DRUG,Asafoetida,,FERULA ASSA-FOETIDA RESIN,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,FERULA ASSA-FOETIDA RESIN,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0574,HUMAN OTC DRUG,Asafoetida,,FERULA ASSA-FOETIDA RESIN,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,FERULA ASSA-FOETIDA RESIN,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0577,HUMAN OTC DRUG,Asarum europaeum,,ASARUM EUROPAEUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ASARUM EUROPAEUM,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0580,HUMAN OTC DRUG,Asarum europaeum,,ASARUM EUROPAEUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ASARUM EUROPAEUM,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0581,HUMAN OTC DRUG,Arsenicum iodatum,,ARSENIC TRIIODIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIIODIDE,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0582,HUMAN OTC DRUG,Arsenicum iodatum,,ARSENIC TRIIODIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIIODIDE,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0585,HUMAN OTC DRUG,Arsenicum iodatum,,ARSENIC TRIIODIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIIODIDE,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0586,HUMAN OTC DRUG,Arsenicum iodatum,,ARSENIC TRIIODIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIIODIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0589,HUMAN OTC DRUG,Arsenicum iodatum,,ARSENIC TRIIODIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRIIODIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0590,HUMAN OTC DRUG,Arsenicum metallicum,,ARSENIC,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0593,HUMAN OTC DRUG,Arum triphyllum,,ARISAEMA TRIPHYLLUM ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARISAEMA TRIPHYLLUM ROOT,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0594,HUMAN OTC DRUG,Arum triphyllum,,ARISAEMA TRIPHYLLUM ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARISAEMA TRIPHYLLUM ROOT,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0597,HUMAN OTC DRUG,Arum triphyllum,,ARISAEMA TRIPHYLLUM ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARISAEMA TRIPHYLLUM ROOT,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0598,HUMAN OTC DRUG,Arum triphyllum,,ARISAEMA TRIPHYLLUM ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARISAEMA TRIPHYLLUM ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0601,HUMAN OTC DRUG,Arum triphyllum,,ARISAEMA TRIPHYLLUM ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ARISAEMA TRIPHYLLUM ROOT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0602,HUMAN OTC DRUG,Arsenicum sulphuratum flavum,,ARSENIC TRISULFIDE,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ARSENIC TRISULFIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0605,HUMAN OTC DRUG,Arsenicum sulphuratum rubrun,,TETRAARSENIC TETRASULFIDE,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,TETRAARSENIC TETRASULFIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0606,HUMAN OTC DRUG,Artemisia vulgaris,,ARTEMISIA VULGARIS ROOT,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ARTEMISIA VULGARIS ROOT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0609,HUMAN OTC DRUG,Arum maculatum,,ARUM MACULATUM ROOT,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ARUM MACULATUM ROOT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0610,HUMAN OTC DRUG,Arundo mauritanica,,ARUNDO PLINIANA ROOT,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ARUNDO PLINIANA ROOT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0613,HUMAN OTC DRUG,Asafoetida,,FERULA ASSA-FOETIDA RESIN,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,FERULA ASSA-FOETIDA RESIN,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0614,HUMAN OTC DRUG,Asarum europaeum,,ASARUM EUROPAEUM WHOLE,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ASARUM EUROPAEUM WHOLE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0616,HUMAN OTC DRUG,Asterias rubens,,ASTERIAS RUBENS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ASTERIAS RUBENS,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0617,HUMAN OTC DRUG,Asterias rubens,,ASTERIAS RUBENS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ASTERIAS RUBENS,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0618,HUMAN OTC DRUG,Asterias rubens,,ASTERIAS RUBENS,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,ASTERIAS RUBENS,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0629,HUMAN OTC DRUG,AURUM IODATUM,,GOLD MONOIODIDE,PELLET,ORAL,20250101,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD MONOIODIDE,200,[kp_C]/200[kp_C],,,N,20261231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0630,HUMAN OTC DRUG,Aurum iodatum,,GOLD MONOIODIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD MONOIODIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0632,HUMAN OTC DRUG,Aurum iodatum,,GOLD MONOIODIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD MONOIODIDE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0636,HUMAN OTC DRUG,Aurum metallicum,,GOLD,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD,8,[hp_X]/1,"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0640,HUMAN OTC DRUG,Aurum muriaticum,,GOLD TRICHLORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD TRICHLORIDE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0644,HUMAN PRESCRIPTION DRUG,Aurum muriaticum kalinatum,,POTASSIUM TETRACHLOROAURATE DIHYDRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,POTASSIUM TETRACHLOROAURATE DIHYDRATE,9,[hp_C]/9[hp_C],"Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0646,HUMAN OTC DRUG,Aurum muriaticum natronum,,SODIUM TETRACHLOROAURATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM TETRACHLOROAURATE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0648,HUMAN OTC DRUG,Aurum muriaticum natronatum,,SODIUM TETRACHLOROAURATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM TETRACHLOROAURATE,4,[hp_C]/4[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0649,HUMAN OTC DRUG,Aurum muriaticum natronatum,,SODIUM TETRACHLOROAURATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM TETRACHLOROAURATE,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0650,HUMAN OTC DRUG,Aurum muriaticum natronatum,,SODIUM TETRACHLOROAURATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM TETRACHLOROAURATE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0656,HUMAN OTC DRUG,Avena sativa,,AVENA SATIVA FLOWERING TOP,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AVENA SATIVA FLOWERING TOP,6,[hp_X]/6[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0657,HUMAN OTC DRUG,Avena sativa,,AVENA SATIVA FLOWERING TOP,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AVENA SATIVA FLOWERING TOP,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0658,HUMAN OTC DRUG,Avena sativa,,AVENA SATIVA FLOWERING TOP,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AVENA SATIVA FLOWERING TOP,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0664,HUMAN OTC DRUG,Aurum metallicum,,GOLD,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD,6,[hp_C]/6[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0665,HUMAN OTC DRUG,Aurum metallicum,,GOLD,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD,9,[hp_C]/9[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0666,HUMAN OTC DRUG,Aurum metallicum,,GOLD,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD,12,[hp_C]/12[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0667,HUMAN OTC DRUG,Aurum metallicum,,GOLD,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD,15,[hp_C]/15[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0668,HUMAN OTC DRUG,Aurum metallicum,,GOLD,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD,30,[hp_C]/30[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0669,HUMAN OTC DRUG,Aurum metallicum,,GOLD,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD,200,[kp_C]/200[kp_C],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0670,HUMAN OTC DRUG,Aurum metallicum,,GOLD,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD,1,[hp_M]/[hp_M],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0671,HUMAN OTC DRUG,Aurum metallicum,,GOLD,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD,10,[hp_M]/10[hp_M],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0672,HUMAN OTC DRUG,Aurum metallicum,,GOLD,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD,30,[hp_X]/30[hp_X],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0674,HUMAN OTC DRUG,Aurum muriaticum,,GOLD TRICHLORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD TRICHLORIDE,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0675,HUMAN OTC DRUG,Aurum muriaticum,,GOLD TRICHLORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD TRICHLORIDE,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0676,HUMAN OTC DRUG,Aurum muriaticum,,GOLD TRICHLORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD TRICHLORIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0677,HUMAN OTC DRUG,Aurum muriaticum,,GOLD TRICHLORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,GOLD TRICHLORIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0731,HUMAN OTC DRUG,Bellis perennis,,BELLIS PERENNIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BELLIS PERENNIS,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0732,HUMAN OTC DRUG,Bellis perennis,,BELLIS PERENNIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BELLIS PERENNIS,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0733,HUMAN OTC DRUG,Bellis perennis,,BELLIS PERENNIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BELLIS PERENNIS,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0734,HUMAN OTC DRUG,Bellis perennis,,BELLIS PERENNIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BELLIS PERENNIS,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0738,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0739,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0740,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0741,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,6,[hp_X]/6[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0742,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,12,[hp_X]/12[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0743,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0747,HUMAN OTC DRUG,Baryta carbonica,,BARIUM CARBONATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM CARBONATE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0748,HUMAN OTC DRUG,Baryta carbonica,,BARIUM CARBONATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM CARBONATE,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0749,HUMAN OTC DRUG,Baryta carbonica,,BARIUM CARBONATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM CARBONATE,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0750,HUMAN OTC DRUG,Baryta carbonica,,BARIUM CARBONATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM CARBONATE,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0751,HUMAN OTC DRUG,Baryta carbonica,,BARIUM CARBONATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM CARBONATE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0752,HUMAN OTC DRUG,Baryta carbonica,,BARIUM CARBONATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM CARBONATE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0753,HUMAN OTC DRUG,Baryta carbonica,,BARIUM CARBONATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM CARBONATE,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0754,HUMAN OTC DRUG,Baryta carbonica,,BARIUM CARBONATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM CARBONATE,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0755,HUMAN OTC DRUG,Baryta muriatica,,BARIUM CHLORIDE DIHYDRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM CHLORIDE DIHYDRATE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0756,HUMAN OTC DRUG,Baryta muriatica,,BARIUM CHLORIDE DIHYDRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM CHLORIDE DIHYDRATE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0759,HUMAN OTC DRUG,Badiaga,,SPONGILLA LACUSTRIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SPONGILLA LACUSTRIS,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0761,HUMAN OTC DRUG,Badiaga,,SPONGILLA LACUSTRIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SPONGILLA LACUSTRIS,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0770,HUMAN OTC DRUG,Baptisia tinctoria,,BAPTISIA TINCTORIA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BAPTISIA TINCTORIA ROOT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0773,HUMAN OTC DRUG,Baptisia tinctoria,,BAPTISIA TINCTORIA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BAPTISIA TINCTORIA ROOT,6,[hp_C]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0774,HUMAN OTC DRUG,Baptisia tinctoria,,BAPTISIA TINCTORIA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BAPTISIA TINCTORIA ROOT,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0775,HUMAN OTC DRUG,Baptisia tinctoria,,BAPTISIA TINCTORIA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BAPTISIA TINCTORIA ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0785,HUMAN OTC DRUG,Baryta carbonica,,BARIUM CARBONATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM CARBONATE,8,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0789,HUMAN OTC DRUG,Baryta iodata,,BARIUM IODIDE,PELLET,ORAL,19830503,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM IODIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0793,HUMAN OTC DRUG,Baryta muriatica,,BARIUM CHLORIDE DIHYDRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM CHLORIDE DIHYDRATE,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0795,HUMAN OTC DRUG,Baryta iodata,,BARIUM IODIDE,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,BARIUM IODIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0797,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,4,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0800,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,3,[hp_C]/3[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0801,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0802,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0803,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0804,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0805,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0808,HUMAN OTC DRUG,Belladonna,,ATROPA BELLADONNA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ATROPA BELLADONNA,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0811,HUMAN OTC DRUG,Bellis perennis,,BELLIS PERENNIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BELLIS PERENNIS,5,[hp_C]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0812,HUMAN OTC DRUG,Bellis perennis,,BELLIS PERENNIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BELLIS PERENNIS,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0815,HUMAN OTC DRUG,Benzinum,,BENZENE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BENZENE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0816,HUMAN OTC DRUG,Bellis perennis,,BELLIS PERENNIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BELLIS PERENNIS,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0817,HUMAN OTC DRUG,Benzinum,,BENZENE,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,BENZENE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0820,HUMAN OTC DRUG,BENZOICUM ACIDUM,,BENZOIC ACID,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,BENZOIC ACID,200,[kp_C]/200[kp_C],"Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0823,HUMAN OTC DRUG,Benzoicum acidum,,BENZOIC ACID,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BENZOIC ACID,6,[hp_C]/6[hp_C],"Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0824,HUMAN OTC DRUG,Benzoicum acidum,,BENZOIC ACID,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BENZOIC ACID,30,[hp_C]/30[hp_C],"Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0825,HUMAN OTC DRUG,Berberis vulgaris,,BERBERIS VULGARIS ROOT BARK,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERBERIS VULGARIS ROOT BARK,3,[hp_C]/3[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0828,HUMAN OTC DRUG,Berberis vulgaris,,BERBERIS VULGARIS ROOT BARK,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERBERIS VULGARIS ROOT BARK,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0829,HUMAN OTC DRUG,Berberis vulgaris,,BERBERIS VULGARIS ROOT BARK,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERBERIS VULGARIS ROOT BARK,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0831,HUMAN OTC DRUG,Berberis aquifolium,,BERBERIS AQUIFOLIUM ROOT BARK,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERBERIS AQUIFOLIUM ROOT BARK,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0832,HUMAN OTC DRUG,Berberis vulgaris,,BERBERIS VULGARIS ROOT BARK,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERBERIS VULGARIS ROOT BARK,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0833,HUMAN OTC DRUG,Berberis vulgaris,,BERBERIS VULGARIS ROOT BARK,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERBERIS VULGARIS ROOT BARK,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0835,HUMAN OTC DRUG,Berberis vulgaris,,BERBERIS VULGARIS ROOT BARK,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERBERIS VULGARIS ROOT BARK,4,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0836,HUMAN OTC DRUG,Berberis vulgaris,,BERBERIS VULGARIS ROOT BARK,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERBERIS VULGARIS ROOT BARK,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0837,HUMAN OTC DRUG,Berberis vulgaris,,BERBERIS VULGARIS ROOT BARK,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERBERIS VULGARIS ROOT BARK,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0839,HUMAN OTC DRUG,Beryllium metallicum,,BERYLLIUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERYLLIUM,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0841,HUMAN OTC DRUG,Berberis vulgaris,,BERBERIS VULGARIS ROOT BARK,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERBERIS VULGARIS ROOT BARK,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0844,HUMAN OTC DRUG,Berberis vulgaris,,BERBERIS VULGARIS ROOT BARK,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERBERIS VULGARIS ROOT BARK,6,[hp_X]/6[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0845,HUMAN OTC DRUG,Berberis vulgaris,,BERBERIS VULGARIS ROOT BARK,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERBERIS VULGARIS ROOT BARK,10,[hp_X]/10[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0848,HUMAN OTC DRUG,Beryllium metallicum,,BERYLLIUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BERYLLIUM,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0851,HUMAN OTC DRUG,Bismuthum metallicum,,BISMUTH,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BISMUTH,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0856,HUMAN OTC DRUG,Bismuthum metallicum,,BISMUTH,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,BISMUTH,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0859,HUMAN OTC DRUG,Bismuthum subnitricum,,BISMUTH SUBNITRATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BISMUTH SUBNITRATE,30,[hp_C]/30[hp_C],"Bismuth [CS], Bismuth [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0865,HUMAN OTC DRUG,BLATTA ORIENTALIS,,BLATTA ORIENTALIS,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,BLATTA ORIENTALIS,200,[kp_C]/200[kp_C],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0868,HUMAN OTC DRUG,Blatta orientalis,,BLATTA ORIENTALIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BLATTA ORIENTALIS,6,[hp_C]/6[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0869,HUMAN OTC DRUG,Blatta orientalis,,BLATTA ORIENTALIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BLATTA ORIENTALIS,9,[hp_C]/9[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0871,HUMAN OTC DRUG,Blatta orientalis,,BLATTA ORIENTALIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BLATTA ORIENTALIS,5,[hp_C]/1,"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0872,HUMAN OTC DRUG,Blatta orientalis,,BLATTA ORIENTALIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BLATTA ORIENTALIS,15,[hp_C]/15[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0873,HUMAN OTC DRUG,Blatta orientalis,,BLATTA ORIENTALIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BLATTA ORIENTALIS,30,[hp_C]/30[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0876,HUMAN OTC DRUG,Borax,,SODIUM BORATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM BORATE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0877,HUMAN OTC DRUG,Borax,,SODIUM BORATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM BORATE,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0880,HUMAN OTC DRUG,Borax,,SODIUM BORATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM BORATE,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0881,HUMAN OTC DRUG,Borax,,SODIUM BORATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM BORATE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0884,HUMAN OTC DRUG,Borax,,SODIUM BORATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM BORATE,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0885,HUMAN OTC DRUG,Borax,,SODIUM BORATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM BORATE,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0887,HUMAN OTC DRUG,Borax,,SODIUM BORATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM BORATE,6,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0888,HUMAN OTC DRUG,Borax,,SODIUM BORATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM BORATE,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0889,HUMAN OTC DRUG,Borax,,SODIUM BORATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM BORATE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0892,HUMAN OTC DRUG,Borax,,SODIUM BORATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SODIUM BORATE,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0895,HUMAN OTC DRUG,Bovista,,LYCOPERDON UTRIFORME FRUITING BODY,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYCOPERDON UTRIFORME FRUITING BODY,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0896,HUMAN OTC DRUG,Bovista,,LYCOPERDON UTRIFORME FRUITING BODY,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYCOPERDON UTRIFORME FRUITING BODY,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0897,HUMAN OTC DRUG,Bovista,,LYCOPERDON UTRIFORME FRUITING BODY,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYCOPERDON UTRIFORME FRUITING BODY,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0900,HUMAN OTC DRUG,Bovista,,LYCOPERDON UTRIFORME FRUITING BODY,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYCOPERDON UTRIFORME FRUITING BODY,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0901,HUMAN OTC DRUG,Bromium,,BROMINE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BROMINE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0904,HUMAN OTC DRUG,Bromium,,BROMINE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BROMINE,6,[hp_X]/6[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0907,HUMAN OTC DRUG,Bromium,,Bromine,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BROMINE,6,[hp_X]/6[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0909,HUMAN OTC DRUG,Bromium,,BROMINE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BROMINE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0915,HUMAN OTC DRUG,Bryonia,,BRYONIA ALBA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BRYONIA ALBA ROOT,4,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0925,HUMAN PRESCRIPTION DRUG,Bufo rana,,BUFO BUFO CUTANEOUS GLAND,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BUFO BUFO CUTANEOUS GLAND,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0939,HUMAN OTC DRUG,Bryonia,,BRYONIA ALBA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BRYONIA ALBA ROOT,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0940,HUMAN OTC DRUG,Bryonia,,BRYONIA ALBA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BRYONIA ALBA ROOT,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0941,HUMAN OTC DRUG,Bryonia,,BRYONIA ALBA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BRYONIA ALBA ROOT,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0942,HUMAN OTC DRUG,Bryonia,,BRYONIA ALBA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BRYONIA ALBA ROOT,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0943,HUMAN OTC DRUG,Bryonia,,BRYONIA ALBA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BRYONIA ALBA ROOT,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0944,HUMAN OTC DRUG,Bryonia,,BRYONIA ALBA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BRYONIA ALBA ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0945,HUMAN OTC DRUG,Bryonia,,BRYONIA ALBA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BRYONIA ALBA ROOT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0946,HUMAN OTC DRUG,Bryonia,,BRYONIA ALBA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BRYONIA ALBA ROOT,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0947,HUMAN OTC DRUG,Bryonia,,BRYONIA ALBA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BRYONIA ALBA ROOT,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0948,HUMAN OTC DRUG,Bryonia,,BRYONIA ALBA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BRYONIA ALBA ROOT,6,[hp_X]/6[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0949,HUMAN OTC DRUG,Bryonia,,BRYONIA ALBA ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BRYONIA ALBA ROOT,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0951,HUMAN PRESCRIPTION DRUG,Bufo rana,,BUFO BUFO CUTANEOUS GLAND,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BUFO BUFO CUTANEOUS GLAND,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0952,HUMAN PRESCRIPTION DRUG,Bufo rana,,BUFO BUFO CUTANEOUS GLAND,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BUFO BUFO CUTANEOUS GLAND,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0953,HUMAN PRESCRIPTION DRUG,Bufo rana,,BUFO BUFO CUTANEOUS GLAND,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BUFO BUFO CUTANEOUS GLAND,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0954,HUMAN PRESCRIPTION DRUG,Bufo rana,,BUFO BUFO CUTANEOUS GLAND,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,BUFO BUFO CUTANEOUS GLAND,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0956,HUMAN OTC DRUG,Calcarea phosphorica,,TRIBASIC CALCIUM PHOSPHATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TRIBASIC CALCIUM PHOSPHATE,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0957,HUMAN OTC DRUG,Calcarea phosphorica,,TRIBASIC CALCIUM PHOSPHATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TRIBASIC CALCIUM PHOSPHATE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0958,HUMAN OTC DRUG,Calcarea phosphorica,,TRIBASIC CALCIUM PHOSPHATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TRIBASIC CALCIUM PHOSPHATE,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0959,HUMAN OTC DRUG,Calcarea phosphorica,,TRIBASIC CALCIUM PHOSPHATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TRIBASIC CALCIUM PHOSPHATE,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0960,HUMAN OTC DRUG,Calcarea phosphorica,,TRIBASIC CALCIUM PHOSPHATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TRIBASIC CALCIUM PHOSPHATE,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0961,HUMAN OTC DRUG,Calcarea phosphorica,,TRIBASIC CALCIUM PHOSPHATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TRIBASIC CALCIUM PHOSPHATE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0962,HUMAN OTC DRUG,Calcarea phosphorica,,TRIBASIC CALCIUM PHOSPHATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TRIBASIC CALCIUM PHOSPHATE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0963,HUMAN OTC DRUG,Calcarea phosphorica,,TRIBASIC CALCIUM PHOSPHATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TRIBASIC CALCIUM PHOSPHATE,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0964,HUMAN OTC DRUG,Calcarea phosphorica,,TRIBASIC CALCIUM PHOSPHATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TRIBASIC CALCIUM PHOSPHATE,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0965,HUMAN OTC DRUG,Calcarea phosphorica,,TRIBASIC CALCIUM PHOSPHATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TRIBASIC CALCIUM PHOSPHATE,8,[hp_X]/8[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0966,HUMAN OTC DRUG,Calcarea phosphorica,,TRIBASIC CALCIUM PHOSPHATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TRIBASIC CALCIUM PHOSPHATE,12,[hp_X]/12[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0967,HUMAN OTC DRUG,Calcarea phosphorica,,TRIBASIC CALCIUM PHOSPHATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TRIBASIC CALCIUM PHOSPHATE,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0970,HUMAN OTC DRUG,Calcarea fluorica,,CALCIUM FLUORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM FLUORIDE,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0971,HUMAN OTC DRUG,Calcarea fluorica,,CALCIUM FLUORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM FLUORIDE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0972,HUMAN OTC DRUG,Calcarea fluorica,,CALCIUM FLUORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM FLUORIDE,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0973,HUMAN OTC DRUG,Calcarea fluorica,,CALCIUM FLUORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM FLUORIDE,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0974,HUMAN OTC DRUG,Calcarea fluorica,,CALCIUM FLUORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM FLUORIDE,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0975,HUMAN OTC DRUG,Calcarea fluorica,,CALCIUM FLUORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM FLUORIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0976,HUMAN OTC DRUG,Calcarea fluorica,,CALCIUM FLUORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM FLUORIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0977,HUMAN OTC DRUG,Calcarea fluorica,,CALCIUM FLUORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM FLUORIDE,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0978,HUMAN OTC DRUG,Calcarea fluorica,,CALCIUM FLUORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM FLUORIDE,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0979,HUMAN OTC DRUG,Calcarea fluorica,,CALCIUM FLUORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM FLUORIDE,12,[hp_X]/12[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0980,HUMAN OTC DRUG,Calcarea fluorica,,CALCIUM FLUORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM FLUORIDE,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0983,HUMAN OTC DRUG,Calcarea carbonica,,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0984,HUMAN OTC DRUG,Calcarea carbonica,,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0985,HUMAN OTC DRUG,Calcarea carbonica,,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0986,HUMAN OTC DRUG,Calcarea carbonica,,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0987,HUMAN OTC DRUG,Calcarea carbonica,,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",12,[hp_X]/12[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0988,HUMAN OTC DRUG,Calcarea carbonica,,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0991,HUMAN OTC DRUG,Calcarea sulphurica,,CALCIUM SULFATE ANHYDROUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM SULFATE ANHYDROUS,6,[hp_C]/6[hp_C],"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0992,HUMAN OTC DRUG,Calcarea sulphurica,,CALCIUM SULFATE ANHYDROUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM SULFATE ANHYDROUS,9,[hp_C]/9[hp_C],"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0995,HUMAN OTC DRUG,Calcarea sulphurica,,CALCIUM SULFATE ANHYDROUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM SULFATE ANHYDROUS,12,[hp_C]/12[hp_C],"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0996,HUMAN OTC DRUG,Calcarea sulphurica,,CALCIUM SULFATE ANHYDROUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM SULFATE ANHYDROUS,15,[hp_C]/15[hp_C],"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-0999,HUMAN OTC DRUG,Calcarea sulphurica,,CALCIUM SULFATE ANHYDROUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM SULFATE ANHYDROUS,30,[hp_C]/30[hp_C],"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1000,HUMAN OTC DRUG,Calcarea sulphurica,,CALCIUM SULFATE ANHYDROUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM SULFATE ANHYDROUS,200,[kp_C]/200[kp_C],"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1003,HUMAN OTC DRUG,Calcarea sulphurica,,CALCIUM SULFATE ANHYDROUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM SULFATE ANHYDROUS,1,[hp_M]/[hp_M],"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1004,HUMAN OTC DRUG,Calcarea sulphurica,,CALCIUM SULFATE ANHYDROUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM SULFATE ANHYDROUS,30,[hp_X]/30[hp_X],"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1006,HUMAN OTC DRUG,Cadmium metallicum,,CADMIUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CADMIUM,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1007,HUMAN OTC DRUG,Cadmium metalllicum,,CADMIUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CADMIUM,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1014,HUMAN OTC DRUG,Cadmium sulphuratum,,CADMIUM SULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CADMIUM SULFIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1015,HUMAN OTC DRUG,Cadmium sulphuratum,,CADMIUM SULFIDE,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,CADMIUM SULFIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1018,HUMAN OTC DRUG,Cadmium sulphuricum,,CADMIUM SULFATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CADMIUM SULFATE,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1020,HUMAN OTC DRUG,Cajuputum,,CAJUPUT OIL,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,CAJUPUT OIL,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1023,HUMAN OTC DRUG,Cadmium sulphuricum,,CADMIUM SULFATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CADMIUM SULFATE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1024,HUMAN OTC DRUG,Cadmium sulphuricum,,CADMIUM SULFATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CADMIUM SULFATE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1027,HUMAN OTC DRUG,Caladium seguinum,,DIEFFENBACHIA SEGUINE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,DIEFFENBACHIA SEGUINE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1030,HUMAN OTC DRUG,Cajuputum,,CAJUPUT OIL,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAJUPUT OIL,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1031,HUMAN OTC DRUG,Caladium seguinum,,DIEFFENBACHIA SEGUINE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,DIEFFENBACHIA SEGUINE,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1032,HUMAN OTC DRUG,Caladium seguinum,,DIEFFENBACHIA SEGUINE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,DIEFFENBACHIA SEGUINE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1034,HUMAN OTC DRUG,Caladium seguinum,,DIEFFENBACHIA SEGUINE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,DIEFFENBACHIA SEGUINE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1035,HUMAN OTC DRUG,Caladium seguinum,,DIEFFENBACHIA SEGUINE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,DIEFFENBACHIA SEGUINE,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1036,HUMAN OTC DRUG,Caladium seguinum,,DIEFFENBACHIA SEGUINE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,DIEFFENBACHIA SEGUINE,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1046,HUMAN OTC DRUG,Calcarea carbonica,,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",8,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1050,HUMAN OTC DRUG,Calcarea carbonica,,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1051,HUMAN OTC DRUG,Calcarea carbonica,,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1052,HUMAN OTC DRUG,Calcarea carbonica,,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1053,HUMAN OTC DRUG,Calcarea carbonica,,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,"OYSTER SHELL CALCIUM CARBONATE, CRUDE",15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1056,HUMAN OTC DRUG,Calcarea caustica,,CALCIUM HYDROXIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM HYDROXIDE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1057,HUMAN OTC DRUG,Calendula officinalis,,CALENDULA OFFICINALIS FLOWERING TOP,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALENDULA OFFICINALIS FLOWERING TOP,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1060,HUMAN OTC DRUG,Calcarea fluorica,,CALCIUM FLUORIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM FLUORIDE,8,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1063,HUMAN OTC DRUG,Calendula officinalis,,CALENDULA OFFICINALIS FLOWERING TOP,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALENDULA OFFICINALIS FLOWERING TOP,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1066,HUMAN OTC DRUG,Calendula officinalis,,CALENDULA OFFICINALIS FLOWERING TOP,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALENDULA OFFICINALIS FLOWERING TOP,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1067,HUMAN OTC DRUG,Calcarea iodata,,CALCIUM IODIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM IODIDE,200,[kp_C]/200[kp_C],"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1069,HUMAN OTC DRUG,Calcarea iodata,,CALCIUM IODIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM IODIDE,30,[hp_C]/30[hp_C],"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1071,HUMAN OTC DRUG,Calendula officinalis,,CALENDULA OFFICINALIS FLOWERING TOP,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALENDULA OFFICINALIS FLOWERING TOP,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1074,HUMAN OTC DRUG,Calendula officinalis,,CALENDULA OFFICINALIS FLOWERING TOP,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALENDULA OFFICINALIS FLOWERING TOP,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1075,HUMAN OTC DRUG,Calendula officinalis,,CALENDULA OFFICINALIS FLOWERING TOP,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALENDULA OFFICINALIS FLOWERING TOP,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1078,HUMAN OTC DRUG,Calendula officinalis,,CALENDULA OFFICINALIS FLOWERING TOP,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALENDULA OFFICINALIS FLOWERING TOP,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1079,HUMAN OTC DRUG,Cantharis,,LYTTA VESICATORIA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYTTA VESICATORIA,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1082,HUMAN OTC DRUG,Cantharis,,LYTTA VESICATORIA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYTTA VESICATORIA,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1083,HUMAN OTC DRUG,Cantharis,,LYTTA VESICATORIA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYTTA VESICATORIA,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1085,HUMAN OTC DRUG,Calcarea phosphorica,,TRIBASIC CALCIUM PHOSPHATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,TRIBASIC CALCIUM PHOSPHATE,6,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1088,HUMAN OTC DRUG,Cantharis,,LYTTA VESICATORIA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYTTA VESICATORIA,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1091,HUMAN OTC DRUG,Cantharis,,LYTTA VESICATORIA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYTTA VESICATORIA,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1092,HUMAN OTC DRUG,Cantharis,,LYTTA VESICATORIA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYTTA VESICATORIA,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1094,HUMAN OTC DRUG,Calcarea silicata,,CALCIUM SILICATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM SILICATE,6,[hp_C]/6[hp_C],"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1095,HUMAN OTC DRUG,Calcarea silicata,,CALCIUM SILICATE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM SILICATE,30,[hp_C]/30[hp_C],"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1098,HUMAN OTC DRUG,Calcarea sulphurica,,CALCIUM SULFATE ANHYDROUS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALCIUM SULFATE ANHYDROUS,6,[hp_X]/1,"Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1103,HUMAN OTC DRUG,Calendula officinalis,,CALENDULA OFFICINALIS FLOWERING TOP,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CALENDULA OFFICINALIS FLOWERING TOP,6,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1104,HUMAN OTC DRUG,Calendula,,CALENDULA OFFICINALIS FLOWERING TOP,OINTMENT,TOPICAL,19880717,,UNAPPROVED HOMEOPATHIC,,Laboratoires Boiron,CALENDULA OFFICINALIS FLOWERING TOP,1,[hp_X]/g,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0220-1105,HUMAN OTC DRUG,Calendula,,CALENDULA OFFICINALIS FLOWERING TOP,GEL,TOPICAL,19930930,,UNAPPROVED HOMEOPATHIC,,Laboratoires Boiron,CALENDULA OFFICINALIS FLOWERING TOP,1,[hp_X]/g,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0220-1108,HUMAN OTC DRUG,Calendula,,CALENDULA OFFICINALIS FLOWERING TOP,GEL,TOPICAL,19900413,,UNAPPROVED HOMEOPATHIC,,Laboratoires Boiron,CALENDULA OFFICINALIS FLOWERING TOP,1,[hp_X]/g,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0220-1109,HUMAN OTC DRUG,Calendula,,CALENDULA OFFICINALIS FLOWERING TOP,CREAM,TOPICAL,20060321,,UNAPPROVED HOMEOPATHIC,,Laboratoires Boiron,CALENDULA OFFICINALIS FLOWERING TOP,1,[hp_X]/g,,,N,20251231,L30.9,"[{""icd10_code"":""L30.9"",""description"":""Dermatitis, unspecified"",""confidence"":0.6,""context"":""skin condition""},{""icd10_code"":""L20.9"",""description"":""Atopic dermatitis, unspecified"",""confidence"":0.2,""context"":""eczema""},{""icd10_code"":""L40.9"",""description"":""Psoriasis, unspecified"",""confidence"":0.2,""context"":""psoriasis""}]",0.60
0220-1111,HUMAN OTC DRUG,Cantharis,,LYTTA VESICATORIA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYTTA VESICATORIA,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1114,HUMAN OTC DRUG,Cantharis,,LYTTA VESICATORIA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYTTA VESICATORIA,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1115,HUMAN OTC DRUG,Cantharis,,LYTTA VESICATORIA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYTTA VESICATORIA,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1118,HUMAN OTC DRUG,Candida albicans,,CANDIDA ALBICANS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CANDIDA ALBICANS,1,[hp_M]/[hp_M],"Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1119,HUMAN OTC DRUG,Candida albicans,,CANDIDA ALBICANS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CANDIDA ALBICANS,10,[hp_M]/10[hp_M],"Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1121,HUMAN OTC DRUG,Camphora,,CAMPHOR (NATURAL),PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAMPHOR (NATURAL),30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1122,HUMAN OTC DRUG,Camphora,,CAMPHOR (NATURAL),PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAMPHOR (NATURAL),200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1123,HUMAN OTC DRUG,Candida albicans,,CANDIDA ALBICANS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CANDIDA ALBICANS,12,[hp_X]/12[hp_X],"Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1126,HUMAN OTC DRUG,Candida albicans,,CANDIDA ALBICANS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CANDIDA ALBICANS,6,[hp_C]/6[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1127,HUMAN OTC DRUG,Candida albicans,,CANDIDA ALBICANS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CANDIDA ALBICANS,9,[hp_C]/9[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1130,HUMAN OTC DRUG,Candida albicans,,CANDIDA ALBICANS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CANDIDA ALBICANS,12,[hp_C]/12[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1131,HUMAN OTC DRUG,Candida albicans,,CANDIDA ALBICANS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CANDIDA ALBICANS,15,[hp_C]/15[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1133,HUMAN OTC DRUG,Candida albicans,,CANDIDA ALBICANS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Laboratoires Boiron,CANDIDA ALBICANS,8,[hp_X]/1,"Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1134,HUMAN OTC DRUG,Candida albicans,,CANDIDA ALBICANS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CANDIDA ALBICANS,30,[hp_C]/30[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1135,HUMAN OTC DRUG,Candida albicans,,CANDIDA ALBICANS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CANDIDA ALBICANS,200,[kp_C]/200[kp_C],"Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1138,HUMAN OTC DRUG,Capsicum annuum,,CAPSICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAPSICUM,9,[hp_C]/9[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1139,HUMAN OTC DRUG,Capsicum annuum,,CAPSICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAPSICUM,30,[hp_C]/30[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1142,HUMAN OTC DRUG,Capsicum annuum,,CAPSICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAPSICUM,200,[kp_C]/200[kp_C],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1145,HUMAN OTC DRUG,Cantharis,,LYTTA VESICATORIA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,LYTTA VESICATORIA,30,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1147,HUMAN OTC DRUG,Capsicum annuum,,CAPSICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAPSICUM,1,[hp_M]/[hp_M],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1150,HUMAN OTC DRUG,Capsicum annuum,,CAPSICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAPSICUM,6,[hp_C]/6[hp_C],"Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]",,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1151,HUMAN OTC DRUG,Carbo animalis,,CARBO ANIMALIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CARBO ANIMALIS,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1154,HUMAN OTC DRUG,Carbo animalis,,CARBO ANIMALIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CARBO ANIMALIS,8,[hp_X]/8[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1156,HUMAN OTC DRUG,Carbo animalis,,CARBO ANIMALIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CARBO ANIMALIS,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1158,HUMAN OTC DRUG,Carbo vegetabilis,,ACTIVATED CHARCOAL,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTIVATED CHARCOAL,8,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1161,HUMAN OTC DRUG,Carbo animalis,,CARBO ANIMALIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CARBO ANIMALIS,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1163,HUMAN OTC DRUG,Carbolicum acidum,,PHENOL,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,PHENOL,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1164,HUMAN OTC DRUG,Carbo animalis,,CARBO ANIMALIS,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CARBO ANIMALIS,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1168,HUMAN OTC DRUG,Carbo vegetabilis,,ACTIVATED CHARCOAL,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTIVATED CHARCOAL,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1169,HUMAN OTC DRUG,Carbo vegetabilis,,ACTIVATED CHARCOAL,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTIVATED CHARCOAL,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1172,HUMAN OTC DRUG,Carbo vegetabilis,,ACTIVATED CHARCOAL,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTIVATED CHARCOAL,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1173,HUMAN OTC DRUG,Carbo vegetabilis,,ACTIVATED CHARCOAL,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTIVATED CHARCOAL,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1176,HUMAN OTC DRUG,Carbo vegetabilis,,ACTIVATED CHARCOAL,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTIVATED CHARCOAL,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1177,HUMAN OTC DRUG,Carbo vegetabilis,,ACTIVATED CHARCOAL,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTIVATED CHARCOAL,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1183,HUMAN OTC DRUG,Carboneum sulphuratum,,CARBON DISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CARBON DISULFIDE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1184,HUMAN OTC DRUG,Carboneum sulphuratum,,CARBON DISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CARBON DISULFIDE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1185,HUMAN OTC DRUG,Carboneum sulphuratum,,CARBON DISULFIDE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CARBON DISULFIDE,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1188,HUMAN OTC DRUG,Carbolicum acidum,,PHENOL,PELLET,ORAL,20240101,,UNAPPROVED HOMEOPATHIC,,Boiron,PHENOL,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1191,HUMAN OTC DRUG,Carduus Marianus,,MILK THISTLE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,MILK THISTLE,6,[hp_X]/6[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1192,HUMAN OTC DRUG,Carduus marianus,,MILK THISTLE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,MILK THISTLE,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1193,HUMAN OTC DRUG,Carduus marianus,,MILK THISTLE,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,MILK THISTLE,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1196,HUMAN OTC DRUG,Carbo vegetabilis,,ACTIVATED CHARCOAL,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTIVATED CHARCOAL,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1197,HUMAN OTC DRUG,Carbo vegetabilis,,ACTIVATED CHARCOAL,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTIVATED CHARCOAL,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1200,HUMAN OTC DRUG,Carbo vegetabilis,,ACTIVATED CHARCOAL,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTIVATED CHARCOAL,12,[hp_X]/12[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1201,HUMAN OTC DRUG,Carbo vegetabilis,,ACTIVATED CHARCOAL,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,ACTIVATED CHARCOAL,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1204,HUMAN OTC DRUG,Caulophyllum thalictroides,,CAULOPHYLLUM THALICTROIDES ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAULOPHYLLUM THALICTROIDES ROOT,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1205,HUMAN OTC DRUG,Caulophyllum thalictroides,,CAULOPHYLLUM THALICTROIDES ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAULOPHYLLUM THALICTROIDES ROOT,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1208,HUMAN OTC DRUG,Caulophyllum thalictroides,,CAULOPHYLLUM THALICTROIDES ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAULOPHYLLUM THALICTROIDES ROOT,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1209,HUMAN OTC DRUG,Caulophyllum thalictroides,,CAULOPHYLLUM THALICTROIDES ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAULOPHYLLUM THALICTROIDES ROOT,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1212,HUMAN OTC DRUG,Caulophyllum thalictroides,,CAULOPHYLLUM THALICTROIDES ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAULOPHYLLUM THALICTROIDES ROOT,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1213,HUMAN OTC DRUG,Caulophyllum thalictroides,,CAULOPHYLLUM THALICTROIDES ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAULOPHYLLUM THALICTROIDES ROOT,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1216,HUMAN OTC DRUG,Causticum,,CAUSTICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAUSTICUM,5,[hp_C]/5[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1217,HUMAN OTC DRUG,Causticum,,CAUSTICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAUSTICUM,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1220,HUMAN OTC DRUG,Causticum,,CAUSTICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAUSTICUM,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1223,HUMAN OTC DRUG,Caulophyllum thalictroides,,CAULOPHYLLUM THALICTROIDES ROOT,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAULOPHYLLUM THALICTROIDES ROOT,30,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1224,HUMAN OTC DRUG,Causticum,,CAUSTICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAUSTICUM,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1227,HUMAN OTC DRUG,Causticum,,CAUSTICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAUSTICUM,6,[hp_X]/1,,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1229,HUMAN OTC DRUG,Causticum,,CAUSTICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAUSTICUM,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1231,HUMAN PRESCRIPTION DRUG,Ceanothus americanus,,CEANOTHUS AMERICANUS LEAF,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CEANOTHUS AMERICANUS LEAF,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1233,HUMAN OTC DRUG,Causticum,,CAUSTICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAUSTICUM,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1235,HUMAN OTC DRUG,Cedron,,SIMABA CEDRON SEED,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,SIMABA CEDRON SEED,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1236,HUMAN OTC DRUG,Causticum,,CAUSTICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAUSTICUM,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1237,HUMAN OTC DRUG,Causticum,,CAUSTICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAUSTICUM,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1239,HUMAN OTC DRUG,Cenchris contortrix,,AGKISTRODON CONTORTRIX VENOM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AGKISTRODON CONTORTRIX VENOM,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1240,HUMAN OTC DRUG,Causticum,,CAUSTICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAUSTICUM,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1241,HUMAN OTC DRUG,Causticum,,CAUSTICUM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,CAUSTICUM,30,[hp_X]/30[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1244,HUMAN OTC DRUG,Cenchris contortrix,,AGKISTRODON CONTORTRIX VENOM,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,AGKISTRODON CONTORTRIX VENOM,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1245,HUMAN OTC DRUG,Chamomilla,,MATRICARIA CHAMOMILLA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,MATRICARIA CHAMOMILLA,6,[hp_C]/6[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1248,HUMAN OTC DRUG,Chamomilla,,MATRICARIA CHAMOMILLA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,MATRICARIA CHAMOMILLA,9,[hp_C]/9[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1249,HUMAN OTC DRUG,Chamomilla,,MATRICARIA CHAMOMILLA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,MATRICARIA CHAMOMILLA,12,[hp_C]/12[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1252,HUMAN OTC DRUG,Chamomilla,,MATRICARIA CHAMOMILLA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,MATRICARIA CHAMOMILLA,15,[hp_C]/15[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1253,HUMAN OTC DRUG,Chamomilla,,MATRICARIA CHAMOMILLA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,MATRICARIA CHAMOMILLA,30,[hp_C]/30[hp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1256,HUMAN OTC DRUG,Chamomilla,,MATRICARIA CHAMOMILLA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,MATRICARIA CHAMOMILLA,200,[kp_C]/200[kp_C],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1257,HUMAN OTC DRUG,Chamomilla,,MATRICARIA CHAMOMILLA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,MATRICARIA CHAMOMILLA,1,[hp_M]/[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1260,HUMAN OTC DRUG,Chamomilla,,MATRICARIA CHAMOMILLA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,MATRICARIA CHAMOMILLA,10,[hp_M]/10[hp_M],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
0220-1261,HUMAN OTC DRUG,Chamomilla,,MATRICARIA CHAMOMILLA,PELLET,ORAL,19830303,,UNAPPROVED HOMEOPATHIC,,Boiron,MATRICARIA CHAMOMILLA,12,[hp_X]/12[hp_X],,,N,20251231,Z51.81,"[{""icd10_code"":""Z51.81"",""description"":""Encounter for therapeutic drug level monitoring"",""confidence"":0.1,""context"":""generic drug therapy""}]",0.10
